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The DHDPS/NAL subfamily of enzymes share a very similar structure while catalysing a wide 
variety of reactions in different biochemical pathways. The structural similarity between 
members allows us to understand how this subfamily of enzymes has evolved. This project 
characterises some of the more obscure enzymes in the DHDPS/NAL subfamily in order to 
investigate evolutionary relationships within this subfamily of proteins. This will be done 
though techniques to investigate the structural states of these proteins as well as their 
solution based structure.  
There are two protein groups under investigation: trans-hydroxybenzylidenepyruvate 
hydratase-aldolase (tHBP-HA), 1-pyrroline-4-hydroxy-2-carboxylate deaminase (HypD).  
tHBPHA catalyses the final step of the naphthalene degradation pathway, it has been 
previously characterised as a trimer. Analytical ultracentrifugation (AUC) has been used to 
probe the oligomeric states of the proteins to confirm if they are similar to the tetrameric 
DHDPS/NAL. tHBPHA was found to be consistent with a tetrameric protein. This was further 
shown through use of Small angle x-ray scattering (SAXS). Structure for tHBP-HA from P. 
fluorescens was solved through X-ray crystallography to 2.2Â, allowing for investigation of 
the active site. The replacement of a tyrosine from the adjacent monomer was the only 
difference in the conserved amino acids within the active site. It was found that tHBPHA 
does not show activity towards the DHDPS substrates.  
The second protein investigated is HypD. HypD is involved in L-Hydroxyproline metabolism 
in bacteria and different groups have labelled it as either a tetrameric or hexameric protein. 
AUC showed that the four HypD proteins were consistent with hexameric proteins and were 
largely different to the reference protein E. coli DHDPS. This was again further shown using 
SAXS. The crystal structure for M. lupine HypD was produced to 2.9Å. The protein fits the 
hexameric architype, further showing that HypD are hexameric. The active site showed no 
interaction with the opposing monomer in the dimer interface, a contrast to the other 
members of the DHDPS/NAL subfamily. This shows that HypD is a novel member of the 
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1. Chapter one : introduction 
 
1.1. A brief overview of the thesis 
 
Study of the dihydrodipicolinate synthase (DHDPS) / N-acetylneuraminate lyase (NAL) subfamily of 
proteins provides an effective way to investigate protein evolution between members of the same 
proteins subfamily. This is due to the high sequence and structural similarities between members of 
this sub family of TIM barrel proteins. While DHDPS and NAL proteins have been well characterised 
due to their importance in different metabolic pathways such as bacteria, archaea and plants, other 
members of this subfamily haven’t been as thoroughly characterised. Due to the lack of information 
on these proteins, their structural and biophysical characteristics are relatively unknown and 
contradictions between different studies appear.  
 
The aim of this master’s thesis is to investigate some of the more obscure members of the 
DHDPS/NAL subfamily of proteins in order to investigate structural similarities between these 
members. These members are: Trans-o-hydroxybenzylidenepyruvate hydratase-aldolase (tHBPHA) 
and Δ1-pyrroline-4-hydroxy-2-carboxylate deaminase (HypD). These proteins have not been as                        
thoroughly studied as DHDPS or NAL, because of this the structural properties of these proteins are 
inconsistent.    
 
 
1.2. The TIM barrel fold 
 
A TIM barrel fold is a conserved protein fold in which eight α-helices surround eight parallel β-sheets 
which form a cavity through the protein. The active site of these proteins is generally located within 
this barrel. This protein fold contains a wide variety of different protein subfamilies which catalyse a 
wide variety of reactions. The high number of proteins which exhibit this fold is estimated to be 
about 10% of all currently known enzymes (Copley and Bork 2000, Nagano, Orengo et al. 2002). All 
TIM barrel proteins have been suggested to have evolved from a common ancestor. This explains 
why such a large number of proteins share a highly conserved fold. The fold itself has likely evolved 
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into its current form and it has been theorised that the barrel evolved from its ancestors who 
possibly possessed half barrel (Lang, Thoma et al. 2000, Hocker, Beismann-Driemeyer et al. 2001). 
 
One subfamily of proteins within this 10% is the DHDPS / NAL subfamily of proteins. This is a family 
which (despite originating from a highly diverse background in numerous metabolic pathways) all 
exhibit the conserved TIM barrel fold and a similar reaction chemistry. There are numerous 
members of this family which catalyse a wide variety of reactions. Despite catalysing a variety of 
different reactions, they exhibit structural and biochemical similarities (Nagano, Orengo et al. 2002). 
A majority of these proteins are classed as aldolase enzymes. Examples of the different reactions 
catalysed by members of this sub family is the reaction of DHDPS which catalyses the condensation 
of pyruvate with l-aspartate β-semialdehyde into the product Dihydrodipicolinate (Blickling, Renner 
et al. 1997). Another example is the reaction of NAL which catalyses the aldol cleavage of sialic acid 
(N-acetylneuraminate) to N-acetyl-D-mannosamine + pyruvate(Uchida, Tsukada et al. 1984). The 
member tHBPHA catalyses the final step of the naphthalene degradation pathway(Eaton and 
Chapman 1992). HypD is involved with the bacterial degradation of hydroxyl proline (Watanabe, 
Kodaki et al. 2006, Watanabe, Yamada et al. 2007) while yet another member (HOG aldolase) 
catalyses the final step of L-hydroxyproline metabolism in mammals, yielding Pyruvate and glyoylate 
as products (Riedel, Johnson et al. 2011). All of these proteins share structural similarities whilst 
catalysing different reactions, showing the diversity of members of this subfamily. 
 
1.2.1. The DHDPS / NAL subfamily of proteins 
 
These members can be described as class one aldolase enzymes. There are two different classes of 
Aldolase enzymes: class one and class two. Class one Aldolase enzymes initially activate a donor 
substrate through formation of a Schiff base intermediate via linkage of an active site residue (eg 
lysine) to a substrate, followed by condensation or cleavage of a substrate. The basic aldol reaction 
involves the condensation of an aldehyde with a ketone (a reaction with an aldol receiver and an 
aldol donor) resulting in the formation of a new carbon to carbon bond (Bolt, Berry et al. 2008).  
Class one Aldolase enzymes do not require the presence of a bivalent metal cofactor which are 




1.2.1.1. Dihydrodipicolinate synthase  
 
One of the well characterised members of this subfamily is DHDPS which is involved in the 
biosynthesis of lysine. Lysine is a key amino acid used for the production of cellular proteins that is 
not synthesised by the human body and therefore must be obtained from dietary sources(Viola 
2001). Lysine is a nutritionally limiting factor in cereal crops, thus (though controversial) genetically 
modifying these crops in order to boost lysine production of these crops is beneficial in increasing 
the amount of dietary lysine available. (Bright and Shewry 1983, Viola 2001). The diaminopimelate 
pathway (DAP) is one of two lysine biosynthetic pathways which exists in bacteria, plants and 
archaea which is involved in the synthesis of lysine (Velasco, Leguina et al. 2002). DHDPS is the first 
committed step of this reaction (figure 1). As previously mentioned, DHDPS catalyses the 
condensation reaction between pyruvate with l-aspartate β-semialdehyde (ASA), forming the 
product (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate (Blickling, Renner et al. 1997). As with 
other members of the Type one Aldolase subfamily, the reaction involves the formation of a Schiff 
base intermediate between the catalytically active lysine within the active site and the substrate 



















The catalytic reaction of DHDPS is shown, beginning with the two substrates l-aspartate β-
semialdehyde (a) and pyruvate (b). Lysine within the active site binds to the pyruvate (c) and a aldol 
bond formation takes place (d). The molecule is dehydrated and the product (2S,4S)-4-hydroxy-2,3,4,5-




Following this, ASA then binds, is dehydrated and the cyclic (2S,4S)-4-hydroxy-2,3,4,5-
tetrahydrodipicolinate is formed along with a water molecule. The lysine residue is important for 
catalytic activity, but its removal won’t prevent pyruvate binding in the active site (da Costa, 
Muscroft-Taylor et al. 2010). An active site mutation which targeted and removed the highly 
conserved lysine residual only resulted in a significant decrease in activity but was still able to be 
catalytically active (da Costa, Muscroft-Taylor et al. 2010).  
 
1.2.1.2.  N-acetylneuraminate lyase 
 
 
Another member of this subfamily is N-acetylneuraminate lyase (NAL). NAL catalyses the reverse 
aldol reaction where sialic acid is cleaved into N -acetylmannosamine and pyruvate (figure 2) (Izard, 
Lawrence et al. 1994, Lawrence, Barbosa et al. 1997).  Sialic acid are nine-carbon amino sugars often 
found on the end of eukaryotic cell surface glycoconjugates (Vimr, Kalivoda et al. 2004) They are 
present in abundance within the human gastrointestinal tract and respiratory system(Jeong, Oh et 
al. 2009), locations where the presence of glucose is a limiting factor for pathogenic colonisation. 
The lack of glucose is combated through evolutionary development of pathways in which to degrade 
sialic acid for use as a nutrient source (Vimr, Kalivoda et al. 2004, Almagro-Moreno and Boyd 2009).  
Sialic acid is imported into the bacterial cell through sialic acid importers with NAL providing the first 
step in sialic acid degradation following its import into the cell. This reaction is reversible (like the 
other reactions from this subfamily) where the reverse reaction synthesises sialic acid. The NAL 
active site shares common elements to DHDPS such as the highly conserved lysine and tyrosine 

























1.2.1.3. Structural similarities between E. coli DHDPS and NAL 
 
All members of the DHDPS/NAL subfamily exhibit the same TIM barrel fold. This fold in highly 
conserved throughout members of this subfamily along with certain key amino acids present within 
the active site. All members of this subfamily all show the presence of lysine within the active site. 
Lysine is key for the aldolase activity of members of this subfamily. This is due to its key part in 
binding the binding of the substrate (primarily pyruvate in most members) and formation of a Schiff 
base between lysine residual and substrate(Laber, Gomisruth et al. 1992). The importance of this 




The catalytic reaction of NAL is shown, Sialic acid (a) has its ring broken and is then and bound to the 
active site lysine (b) via Schiff base pairing to the terminal ε-amine. This is then cleaved into N-







In E. coli NAL, when the conserved lysine residual was mutated to alanine, the enzymatic activity was 
rendered completely inactive. Another mutation to arginine resulted in the enzyme retaining about 
3% of its original activity towards sialic acid (Kruger, Schauer et al. 2001). This shows a similar case 
for E. coli DHDPS which in which the same mutations were performed. There was significant 
decrease in activity for both mutations lysine into alanine (0.06 ± 0.02s-1) and arginine (0.16 ± 0.06s-
1) when compared to the original activity of E. coli DHDPS (45 ± 3s-1) (da Costa, Muscroft-Taylor et al. 
2010). These studies show the importance of lysine within the active site of members of this 
subfamily.  
 
Both E. coli DHDPS and NAL share a high sequence and structural similarity. Both are tetrameric 
proteins and follow the same catalytic mechanism (Laber, Gomisruth et al. 1992, Izard, Lawrence et 
al. 1994). Figure 3, a) Shows both E. coli DHDPS (1YXC) and NAL (1NAL) monomers overlaid showing 
the high similarity with both TIM barrel proteins. The active site consists of three key amino acids 
and a tyrosine which protrudes into the active site from the monomer–monomer interface. Figure 3, 
b) shows the alignment of both active sites. The key residues in E. coli DHDPS are: T44, Y133, K161 
from within one monomer and Y107 from the opposing monomer (Laber, Gomisruth et al. 1992). E. 
coli NAL show the key enzymatic residues of: S47, Y137, and K165 from within the monomer and 
Y110 from the opposing monomer (Izard, Lawrence et al. 1994). The highly conserved active site 
residues shared between the two proteins is shown with the position of these key amino acids. 
Because of this high similarity between members of this subfamily, it provides a good platform to 



























The similarities between the members of this subfamily is further shown with figure 4. This figure 
shows four different members of this subfamily. E. coli DHDPS (a) and A. thaliana DHDPS (b) show a 
different orientation. There is some variation between these members such as DHDPS from A. 
thaliana (plant) and E. coli (bacteria) which show a flipped orientation (Griffin, Billakanti et al. 2012). 
As previously mentioned, E. coli NAL (c) shares a similar orientation to E. coli DHDPS which is shown 
with a comparison between the two tetrameric structures. S. meliloti MOSA (d) is another member 
of this subfamily and is present in a similar tetrameric fold. They all are members of the DHDPS/NAL 
subfamily, exhibiting a homotetrameric orientation. The highly conserved fold is prevalent within all 





E. coli DHDPS (1yxc: cyan) and NAL (1NAL: green) monomers were aligned (a) to show the high similarity 
within the conserved TIM barrel fold. The active sites of the two proteins were aligned (b) showing the 
highly conserved and similar amino acids within. DHDPS residues are coloured green (black text) while 




































This figure shows the tetrameric structures of different members of the DHDPS/NAL subfamily of 
proteins. a) E. coli DHDPS, b) A. thaliana DHDPS, c) E. coli NAL and S. meliloti MOSA. α-helices are 








1.2.1.4. Sequence alignment of members of the DHDPS/NAL 
subfamily. 
 
To further highlight the similarities between the different members of this subfamily, a sequence 
alignment of a few members of this subfamily was performed. Figure 5 shows a sequence alignment 
of a number of these subfamily members. This figure shows conserved residues which are 
highlighted in red surrounded by a blue box. The secondary structure of E. coli DHDHPS is also shown 
along the top of the sequence alignment to represent where the different β-sheets and α-helix are 
positioned. There are a large number of residuals which are conserved throughout the subfamily.  
 
In E. coli DHDPS the key active site residuals are: T44, Y133, K161 and Y107, they are highly 
conserved throughout all DHDPS and some other members. Y133 is conserved throughout most 
members, being present within the active site. Y107 from the opposite monomer is also conserved 
throughout a number of members but with some variation.  K161 is a key residual that forms a 
covalent intermediate with pyruvate (Laber, Gomisruth et al. 1992, Blickling, Renner et al. 1997) 
which is why it is conserved throughout all members. Its absence results in a significant drop in 
enzymatic activity as was mentioned previously (da Costa, Muscroft-Taylor et al. 2010). These 
conserved active site residues is expected due to all members of the DHDPS/NAL subfamily react to 






































































This figure shows the sequence alignments of members of the DHDPS/NAL subfamily of proteins. In 
descending order;  E. coli DHDPS, A. thaliana DHDPS, Pseudomonas aeruginosa DHDPS, Acinetobacter 
baumannii DHDPS, Staphylococcus aureus NAL,  E. coli NAL, Xenopus tropicalis NAL, Sinorhizobium 
meliloti MOSA, Bacillus licheniformis KDGA, Pseudomonas aeruginosa KDGA, Pleomorphomonas 
diazotrophica DOGDH and Pseudomonas putida DOGDH. This information is displayed using espript 
software (Robert and Gouet 2014) with secondary structure of E. coli DHDPS being shown along the top.  
Highly conserved residues throughout most proteins are shown in red surrounded by a blue box while 





1.3. Aim of thesis 
 
The aim of this thesis is to investigate some of the more obscure members of this subfamily in order 
to determine their structural characteristics in relation to this subfamily. This will involve use of 
various techniques to probe the structural characteristics such as: Analytical ultracentrifugation 
(AUC), small angle x-ray scattering (SAXS) and x-ray crystallography. The reason for the structural 
characterisation is due to different studies reporting interesting or contrasting facts about these 
proteins that diverge from the typical members of the DHDPS/NAL subfamily. The possibility for 
DHDPS activity will also be determined through kinetic assay and DSF.  
 
1.4. Proteins of interest 
1.4.1.  trans-Hydroxybenzylidenepyruvate hydratase-aldolase 
(tHBPHA) 
 
The first protein family which will be investigated is trans-Hydroxybenzylidenepyruvate hydratase-
aldolase (tHBPHA). This protein catalyses the final step of the naphthalene degradation pathway and 
is a member of the DHDPS/NAL subfamily of proteins therefor expressing the conserved fold and a 
similar active site architecture. Previous studies have characterised some aspects of this protein but 
have produced some interesting results. (Chen et al) investigated tHBPHA from Pseudomonas 
uesicularis and estimated that the total molecular weight of tHBPHA was about 120 kDa with a likely 
trimeric orientation present. This estimate was based off Gel results but, if correct, could result in a 
trimeric member of the DHDPDS/NAL subfamily. How this oligomeric state will affect the catalytic 










1.4.2. Δ1-pyrroline-4-hydroxy-2-carboxylate Deaminase (HypD) 
 
The protein Δ1-pyrroline-4-hydroxy-2-carboxylate Deaminase (HypD) is another member of the 
DHDPS/NAL subfamily. It is involved in the degradation of hydroxyproline. This protein seems to 
have evolved from the same subfamily of DHDPS/NAL but its catalytic mechanism is different in the 
fact that pyruvate is not present as a product or substrate (Watanabe, Kodaki et al. 2006, Watanabe, 
Yamada et al. 2007).  One interesting point about HypD proteins which have been unclear is the 
oligomeric state. Two different papers have produced contrasting evidence on which oligomeric 
state HypD exists as. Chen et al investigated HypD from S.meliloti and concluded that the oligomeric 
state is in a tetrameric orientation similar to the other members of the DHDPS/NAL subfamily (Chen, 
White et al. 2016). This contrasts to A.tumefaciens HypD which is reported to exist in a hexameric 
orientation (pdb:2HMC). This result contrasts to other members of this subfamily and is another one 
of the main points this thesis will investigate. The possible mechanism of HypD is also interesting 
due to only lysine and tyrosine being conserved within the active site, suggesting that different 















2.    Chapter two: tHBPHA is a trimeric protein? 
2.1. Introduction into the second chapter. 
 
Due to the high structural similarity shared between the members of the DHDPS/NAL 
subfamily of proteins, analysing the evolution of proteins in this subfamily is possible. Some 
of the more obscure members of this subfamily exhibit possibly interesting characteristics 
which is not present with the other, well characterised members of this sub family. This 
chapter aims to structurally characterise one possibly novel member of this subfamily which 
has been reported as a possible trimeric protein.  
  
One example of this is trans-hydroxybenzylidenepyruvate hydratase-Aldolase (tHBPHA). 
THBPHA is an enzyme which catalyses the final step of the naphthalene degradation 
pathway. Naphthalene is a fused polycyclic aromatic hydrocarbon that act as a building 
block for azo dyes and other industrial chemicals. They are often part of industrial 
contamination into aqueous ecosystem (Cerniglia 1984). There are bacteria (such as 
Pseudomonas) that have evolved pathways to degrade environmental naphthalene, 
allowing for naphthalene to become a useable carbon source (Cerniglia 1984). 
 
The naphthalene degradation pathway takes naphthalene of one of its derivatives (such as 
naphthalenesulfonate) and proceeds to metabolize naphthalene. This results in the reaction 
of trans-o-hydroxybenzylidenepyruvate which undergoes an aldol cleavage to form pyruvate 








2.1.1. The final step of naphthalene degradation 
 
The tHBPHA protein catalyses the final step of the naphthalene degradation pathway 
(Kuhm, Knackmuss et al. 1993). Naphthalene is degraded along the pathway until the 
substrate trans-hydroxybenzylidenepyruvate (tHBP) is reduced, which then undergoes an 
aldol cleavage by tHBPHA. This reaction is shown with (figure 6) where tHBP is cleaved into 
salicylaldehyde and pyruvate. Pyruvate is involved in most reactions from members of the 
DHDPS/NAL subfamily of proteins, suggesting that the reaction mechanism could be similar. 
This is shown with the reaction mechanism involving the binding of the highly conserved 














a) b) c) d) 
e) 
Figure 6 
The final reaction of the naphthalene degradation pathway is catalysed by tHBPHA. The 
substrate tHBP (a) binds within the active, forming a Schiff base with K183 (b), the 
double bond is then hydrolysed (c) before substrate cleavage into salicylaldehyde (d) and 
pyruvate (e).  
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2.1.2. Sequence alignments of members of the subfamily with tHBPHA 
In order to investigate tHBPHA with regards to the other members of the DHDPS/NAL 
subfamily, a multiple sequence alignment was produced for members of the DHDPS/NAL 
subfamily with multiple tHBPHA proteins (Sievers, Wilm et al. 2011). The proteins included 
in the alignment are: Pseudomonas fluorescens tHBPHA, Sphingobium xenophagum tHBPHA, 
Escherichia coli DHDPS and E. coli NAL.  The crystal structure of tHBPHA from P. fluorescens 
was produced with the work within this thesis and the secondary structure is shown along 
the top of the alignment. As expected, there are multiple similarities between the members 
within the DHDPS/NAL subfamily of proteins.  
 
One point is a difference between DHDPS and tHBPHA within the active site. The key active 
site residues for E. coli DHDPS are T44, K161, Y133 and Y107 (Laber, Gomisruth et al. 1992). 
The sequence alignment shows that the key amino acid residues present within the E. coli 
DHDPS active site are mostly present in tHBPHA from P. fluorescens. These are T44 with 
tHBPHA T65, Y133 with tHBPHA Y155 and K161 with tHBPHA K183. The main difference with 
the two active sites is that DHDPS Y107 is replaced with W128. K161 performs a nucleophilic 
attack with its amino group to the keto group of the pyruvate (Blickling, Renner et al. 1997). 
Y133 of DHDPS is in involved in Schiff base formation with pyruvate and acts to help stabilise 
the initial reaction. Both enzymes involve use of the substrate pyruvate in their respective 
catalysis step, which is why these amino acids are present within the active site of both 
members. Y107, T44 and Y133 are involved in the formation of a catalytic triad, which is 
important in maintaining the activity of DHDPS, with Y107 also being involved with Y106 in 
the formation of a hydrophobic stack which is involved in enzymatic inhibition when lysine is 
present (Blickling, Renner et al. 1997). The lack of Y107 in tHBPHA is due to there being no 
need to inhibit the enzyme with lysine as in DHDPS but the tryptophan group might still act 






















This figure shows the sequence alignments of members of the DHDPS/NAL subfamily of proteins. In 
descending order: P. fluorescens tHBPHA, S. xenophagum tBHPHA, E. coli DHDPS and E. coli NAL. This 
information is displayed using (escript3.0) software (Robert and Gouet 2014) with secondary structure of 
P. fluorescens tHBPHA being shown along the top.  Highly conserved residuals throughout most proteins 
are shown in red surrounded by a blue box while residuals conserved throughout all members are 





2.1.3. Possible other  enzymatic activity 
 
Due to the similarities between the structures of members of the DHDPS/NAL subfamily, the 
possibility for the enzymes to be promiscuous and participate in multiple enzymatic 
pathways could occur. (Joerger, Mayer et al. 2003) performed specific point mutations on E. 
coli NAL scaffold which resulted in a switch in activity towards DHDPS. While the total 
sequence identity was below 24% between the two, the overall three dimensional shape is 
very similar (Joerger, Mayer et al. 2003). They found that one point mutation (L142R) in E. 
coli NAL was sufficient to significantly increase the activity of the mutant for the DHDPS 
substrate ASA. A 19 fold increase in activity towards this ASA when compared to the residual 
activity of the NAL wildtype (Joerger, Mayer et al. 2003).  
 
An E. coli DHDPS with a mutation in Tyr107 to become phenylalanine to remove the 
hydroxyl group from the active site resulted in a tenfold loss in activity. This loss (while 
significant) wasn’t as large of loss as other mutants, it was speculated that water molecules 
were able to pass through the dimer interface towards the phenylalanine mutant, resulting 
in a water molecule in the position similar to the hydroxyl of tyrosine (Dobson, Valegard et 
al. 2004, Griffin, Dobson et al. 2008). The tryptophan in the tHBPHA active site could share a 
similar effect, resulting in DHDPS activity.  
 
The tHBPHA aldol activity was initially assayed by for the first time by (Ferrara et al) who 
found that the apparent Km and vmaxvalues for the his tagged P. fluorescens tHBPHA was the 
same (for both its natural substrate from the degradation pathway and for benzaldehyde) 
(Ferrara, Mapelli et al. 2011).  (Sello and Di Gennaro 2013) also assessed the ability of P. 
fluorescens tHBPHA to use a variation of different aldehydes as a reaction substrate. They 
found that while being strictly pyruvate depended, the use of different aldehydes as 
acceptors depending on the electronic characteristics of the aldehyde (Sello and Di Gennaro 
2013). The fact that tHBPHA can use different aldehydes as a substrate suggests that a 
DHDPS activity could be possible. Paired with the high similarity with conserved residues 
within the active site this becomes even more possible.  
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2.1.4. Previous structural characterisation of tHBPHA  
 
A previous study characterised tHBPHA from Pseudomonas uesicularis in the 1990’s. Using gel 
filtration, they estimated the molecular weight to be about 120 kDa. Further using gel 
electrophoresis to estimate the molecular weight of the tHBPHA monomer. They estimated a weight 
of about 38 kDa, and concluded that he presence of a trimeric protein(Kuhm, Knackmuss et al. 
1993). This is an interesting point due to members of the DHDPS/NAL subfamily existing primarily as 
tetramers. If this oligomeric state is correct then the presence of a novel member of this subfamily 
has appeared. No apparent structural characterisation of tHBPHA has been taken.  
 
2.1.5. Aims of this chapter 
 
The aim of this chapter is to investigate the structural characteristics of tHBPHA. This will 
involve investigating the oligomeric state in order to determine if it is a trimeric or 
tetrameric protein. Techniques such as: Analytical ultracentrifuge (AUC), Small angle xray 
scattering (SAXS), xray crystallography, will probe the structural properties of tHBPHA while 















2.2.1. Purification of the tHBPHA proteins 
 
The two tHBP-HA proteins are purified to begin the structural investigation of the family. 
Two proteins are purified from the species P. fluorescens (Ferrara, Mapelli et al. 2011) and 
S. xenophagum. Both proteins were transformed into BL21 (DE3) cells and were grown and 
purified as described in the methods using His tag purification followed by TEV cleavage and 
SEC chromatography. P. fluorescens tHBPHA showed high levels of expression with ~20-30 
mg of protein being expressed from 1.6 L of media. S. xenophagum tHBPHA showed a much 
lower level of expression with ~2-5 mg of protein purified from 1.6 L of media. E. coli DHDPS 
and NAL showed high expression levels with purified protein exceeding 40+ mg/ml from 1.6 
L of media.  
 
2.2.2. Analytical Ultracentrifugation of tHBPHA  
 
2.2.2.1. Sedimentation of tHBPHA 
 
The four proteins were analysed and show a similar sedimentation coefficient. The 
experiment showed E. coli DHDPS with a sedimentation value of 7.25 S, compared to the 
values of P. fluorescens tHBPHA of 7.0 S and S. xenophagum tHBPHA of 7.1 S. All three 
proteins show a similar sedimentation suggesting that the oligomeric state is similar. This 
suggests that the tHBPHA proteins are tetrameric not trimeric. E. coli DHDPS and S. 
xenophagum tHBPHA seem to possibly have another species present at 4.5-5 S which could 
be in line with a dimer or trimer. Its presence shouldn’t be large enough to influence the 


































AUC Sedimentation velocity experiments with; 0.5 mg/ml E. coli DHDHPS, 0.4 mg/ml P. 
fluorescens tHBPHA and 0.2 mg/ml S. xenophagum tHBPHA. DHDPS is used as the 






The tetrameric state isn’t influenced by the concentration of tHBPHA. To determine if the 
oligomeric state of tHBPHA is influenced by protein concentration, AUC sedimentation 
velocity was used with varying concentrations of P. fluorescens tHBPHA (figure 9).  The 
experiment used varying concentrations of tHBPHA at 0.1 mg/ml, 0.2 mg/ml and 0.4 mg/ml. 
All three shared a similar sedimentation coefficient of ~7 S with no other species being 





















AUC sedimentation velocity of three different concentrations of P. fluorescens tHBPHA; 0.1 mg/ml, 
0.2 mg/ml and 0.4 mg/ml. This shows that the tetrameric orientation isn’t concentration depended 
as at no point does the presence of a dimer / trimer appear.  
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2.2.2.2. Molecular Mass of the tHBPHA Proteins 
 
Figure 10 shows the molecular weights both P. fluorescens and S. xenophagum tHBPHA as 
calculated through AUC sedimentation velocity with both showing a molecular mass 
corresponding with a tetrameric protein. The theoretical Molecular weight of P. fluorescens 
tHBPHA monomer is 36.9 kDa, giving a theoretical trimeric weight of 110.826kDa and a 
tetrameric weight of about 147.8 kDa. The molecular mass for P. fluorescens tHBPHA 
determined using AUC is 147.6 kDa (figure 10, a)). There is only a slight difference between 
the theoretical and the calculated molecular masses, showing that this protein is in a 
tetrameric orientation. 
S. xenophagum tHBPHA shows a theoretical monomer weight of 35.5 kDa with a trimeric 
weight of 106.4 kDa and a tetrameric weight of 141.8 kDa. The molecular mass for S. 
xenophagum tHBPHA was calculated at 145.6 kDa (figure 10, b)). As with P. fluorescens 
tHBPHA, this value is consistent with a tetrameric protein when compared to the theoretical 














AUC sedimentation velocity data showing the calculated molecular mass of the tHBPHA proteins.  These graphs show 




2.2.3. Small angle x-ray scattering 
2.2.3.1. Intensity Data 
 
In order to determine the solution structure of tHBPHA proteins, small angle x-ray scattering 
(SAXS) is employed. Samples of P. fluorescens and S. xenophagum tHBPHA were examined 
using SAXS along with tetrameric E. coli DHDPS and NAL as references (figure 11).  
 
E. coli DHDPS and NAL were used as a reference for a tetrameric proteins as well as a quality 
control to ensure that the weights aren’t influenced by on site issues. The calculated weight 
from SAXS showed 139.3 kDa for E. coli DHDPS which has a theoretical tetrameric weight of 
125 kDa. SAXS data for E. coli NAL estimated the molecular weight of 134.527kDa which is 
comparable to the theoretical tetrameric weight of 130.5 kDa.  
 
P. fluorescens tHBPHA produced a porod volume of 203406. The zero scattering angle (I0) 
value is 0.071, the radius of gyration (Rg) is 33.48. The calculated molecular weight produced 
from SAXS is about 141 kDa. When compared to the theoretical sequence weights, the 
result is closer to the theoretical tetrameric weight of 147.8 kDa, showing the presence of a 
tetrameric protein. 
 
S. xenophagum tHBPHA showed a porod volume of 178111, an I0 of 0.04 and an Rg of 35.01. 
SAXS produced a molecular weight of about 126.4 kDA protein. This is somewhat 
comparable to both the theoretical tetramer (141.8 kDa) and theoretical trimer (106.3 kDa). 
This result also suggests that a tetrameric protein is likely to be present. The large difference 
between both tHBPHA proteins could be due to quality of S. xenophagum tHBPHA or 






























SAXS data for intensity plots are shown with E. coli DHDPS, E. coli NAL, P. fluorescens tHBPHA and 
S. xenophagum tHBPHA. The four plots are normalised and overlaid showing the similarities 




2.2.3.2. p(r) Distribution Plots 
 
(Figure 12) shows a distance distribution plot of the four proteins. From the calculated 
molecular weights we can see that all four proteins exhibit a similar oligomeric state. Four 
protein p(r) plots are normalised and aligned this shows that both tHBPHA and the 
tetrameric reference proteins of E. coli DHDPS and NAL all share a similar p(r) distribution 
resulting from a similar presence in solution. This shows that, within solution, all four 
proteins exist in a similar state. This state is similar to the state that DHDPS/NAL exists as or 
the p(r) plot would show a different distribution. With the exception of E. coli DHDPS, the 
maximum partial size of both P. fluorescens and S. xenophagum tHBPHA as well as E. coli 


















The p(r) distributions for E. coli DHDPS, E. coli NAL, P. fluorescens tHBPHA and S. xenophagum 
tHBPHA. All four p(r) distributions are overlaid showing a similar distribution resulting 
from existing in a similar state in solution. The maximum dimensions of the proteins are 
also consistent (with exception of DHDPS).   
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2.2.3.3. Kratky plots showing folded protein  
 
Kratky plots are calculated from intensity data and are used to determine data quality and 
how well folded the suspect protein is (Putnam, Hammel et al. 2007). Figure 13 shows all 
four Kratky plots for: P. fluorescens tHBPHA, S. xenophagum tHBPHA, E. coli DHDPS and E. 
coli NAL. All four proteins show a similar Kratky plot with a single, uniform peak between 0-






















SAS data was modelled in a Kratky plot, the figures show: E. coli DHDPS (a), E. coli NAL (b), P. fluorescens 
tHBPHA (c) and S. xenophagum tHBPHA (d). The smooth peak frim 0-0.1Å shows that each protein is 
globular within solution as opposed to fold.  
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2.2.4. X-ray crystallography of  P. fluorescens tHBPHA 
 
2.2.4.1. Solving the crystal structure 
 
In order to further probe the active site architecture to investigate the structural 
consequences of the alternate residues, x-ray crystallography trials were conducted. From 
the PACT suite, the condition which produced the best crystal diffraction data was well G7 
(0.2M Sodium malonate dibasic monohydrate with 20% w/v PEG 3350) which diffracted to 
2.2 Å. Molecular replacement was done using AUTO-RICKSHAW from the Australian 
synchrotron (Panjikar, Parthasarathy et al. 2005, Panjikar, Parthasarathy et al. 2009). 
Initially, molecular replacement was unsuccessful but through production of a second, lower 
resolution crystal in the space group I4122.  
 
 Auto Rickshaw initially used Pirate, a programme which statistically modifies the phase 
probability distributions from experimental phasing to produce an improved version of the 
phase probability distributions to aim to calculate a clearer map (Cowtan 2000). This 
followed with the use of SHELXE for further phase and density modification (Sheldrick 2010). 
Auto Rickshaw then used the program buccaneer to produce a model suitable for molecular 
replacement. Buccaneer is automated program used for protein model building (Cowtan 
2006, Cowtan 2008). This was done effectively by ‘growing’ a backbone within the electron 
density following use of probability functions to predict the orientation of the side chains 
and where they sit with the density. (Cowtan 2006, Cowtan 2008)Through use of AUTO-
RICKSHAW (Panjikar, Parthasarathy et al. 2005, Panjikar, Parthasarathy et al. 2009) and 
Buccaneer (Cowtan 2006, Cowtan 2008), a molecular replacement model was produced and 
structure refined. This was then used to solve the original diffraction pattern. The r-word 







2.2.4.2. tHBPHA crystal structure is in a tetrameric orientation 
 
2.2.4.2.1. Monomeric structure of tHBPHA. 
 
The structure of tHBPHA was solved to 2.2 Å. Its structure exhibits similarities to that of 
DHDPS/NAL with the highly conserved TIM barrel fold being represented in the tHBPHA 
family. This is shown with (Figure 14, a)), the monomer consists of eight β-sheets 
surrounded by eight α-helices as is the standard for members of the DHDPS/NAL subfamily 
of proteins. There are a further three α-helices which aren’t a part of the barrel by are 
present to the side. (Figure 14, b)) shows the inverted monomer with the presence of a 


















The crystal structure of the P. fluorescens tHBPHA monomer is reported with: α-helices are 
shown in red, are β-sheets shown in yellow and the remaining chain in green. The structure 
consists of eight β-sheets and twelve α-helices.  The active site is present within the barrel similar 




2.2.4.2.2. Tetrameric Structure of tHBPHA 
 
The tHBPHA structure is shown to exist as a tetrameric protein (as supported with AUC and 
SAXS results) which is consistent with that of DHDPS/NAL. Similar to DHDPS and NAL, 
tHBPHA seems to assemble as a dimer of dimers. This is expected due to tHBPHA being a 
member of the same subfamily. The homo-tetrameric structure of tHBPHA is shown in 
(Figure 15), the active site is within each barrel and involves interactions with the opposing 




















The tetrameric orientation of tHBPHA from P. fluorescens is shown with: α-
helices are shown in red, are β-sheets shown in yellow and the remaining 
chain in green. The structure fits the tetrameric orientation well and doesn’t 
seeming show the possibility for a trimeric orientation.  
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2.2.4.2.3. The tHBPHA theoretical crystal scatter compared to 
solution scatter produced from SAXS 
 
To probe if the tetrameric crystal structure is consistent with that of the solution structure 
determined with SAXS, the theoretical scatter from the tHBPHA crystal structure was 
compared to the scatter produced from the solution with SAXS. The program Crysol 
(Svergun, Barberato et al. 1995) was used to compare the scatter as shown with Figure 16. 
The figure shows the theoretical scatter of the tetrameric structure (figure 16, a)) and 
dimeric structure (figure 16,b)) which is compared to the actual tHBPHA scatter from SAXS. 
A low Chi2 value of 0.215 was produced for the tetrameric structure while a much higher 
Chi2 value of 62.667 was produced from the dimeric structure. The significant difference in 
the chi2 values between the two structures show that the tetrameric structure is present 
within the solution. This further confirms that the tetrameric structure for tHBPHA is the 
















This figure shows the theoretical scatter from the P. fluorescens crystal structure (black line) and 
compares it to the scatter (red dots) from the solution structure to determine if the crystal 
structures oligomeric state is valid in solution. Figure a) shows a dimeric tHBPHA while the 
tetrameric orientation is shown in b). The dimeric structure produced a chi2 value of 63.33 while the 




2.2.4.2.4. Speculation of the tHBPHA Active site. 
 
The active site of tHBPHA is highly conserved from the DHDPS/NAL subfamily of proteins. 
They share a similar active site with regards to what residues are present within the active 
site. Whilst the crystal structure hasn’t been produced with substrate bound in the active 
site, due to the similarities between members of the DHDPS/ NAL subfamily, the amino 
acids that are involved in catalysis can be speculated.   
 
Due to the sequence similarities between members of the DHDPS/NAL subfamily, the key 
amino acids which are conserved are likely to be present across the members. This is true in 
the active site of tHBPHA and is clearly seen when looking at the sequence alignment (figure 
7). The three residues that are conserved are; T65, Y155, K183. The different between 
DHDPS and tHBPHA is the presence of W128 instead of tyrosine in DHDPS. Y107 in E. coli 
DHDPS is important for catalytic function due to its involvement as part of the catalytic triad 
as well as hydrophobic stacking with the opposite tyrosine (Blickling, Beisel et al. 1997, 
Dobson, Griffin et al. 2005).  Y107 in DHDPS also acts to form a hydrophobic stack with 
Tyrosine 106 within the active site (Reboul, Porebski et al. 2012). While tHBPHA can use 
W128 to mimic the hydrophobic tyrosine in DHDPS, there isn’t another aromatic amino acid 
group next to the tryptophan in which to stack with. The presence of F161 however is in 
close proximity to the tryptophan which could allow for a hydrophobic stacking effect to 
occur. 
 
As with DHDPS, the active site will involve the participation of the opposite monomer of 
tHBPHA. W128 can extend into the opposing active site in a similar manner to how Tyrosine 
does in DHDPS. This is shown with (Figure 17) where the first chain in green (showing T44, 
Y155, and K183 within the active site) also contains W128 which extended form the second 






























The key residues of P. fluorescens tHBPHA are shown. Lysine is involved in binding of 
pyruvate and can face towards the other amino acids within the active site. Threonine 
and tyrosine could interact with tryptophan within the active site similar to how tyrosine 
does in DHDPS. Tryptophan inserts itself into the active site from the opposing 









2.2.4.3. Alignment of tHBPHA to  E. coli DHDPS  
2.2.4.3.1. Alignment of two Monomers 
 
The monomer of tHBPHA was overlaid with the monomer of E. coli DHDPS (1YXC) (Dobson, 
Griffin et al. 2005) as shown in (Figure 18) The TIM barrel fold is extremely similar with only 
some slight variation between them which is due to both proteins belonging to the same 
subfamily. There is variation in the other α-helices not present in the TIM barrel. The 



















The monomeric structure of tHBPHA was aligned to that of E. coli DHDPS (1YXC) (Dobson, Griffin 
et al. 2005)  from a view looking down on the monomer. There is a slight variation between the 
two proteins with regards to the barrel but it exhibits a high level of similarity as expected form a 
member of the same subfamily. The main variation between the two proteins is due to the 
additional helices to the side of the barrel.  
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2.2.4.3.2. Alignment of the  tHBPHA and DHDPS active sites 
 
Figure 19 shows the active sites of tHBPHA and E. coli DHDPS aligned. They both share 
similarities in where the amino acids are positioned. The lysine of tHBPHA seems to be in a 
different position from the DHDPS counterpart. This is likely due to the lack of a substrate 
present to interact with the lysine group. If pyruvate were to be present in the tHBPHA 
structure, K183 would likely be facing toward the other amino acids in the active site. T65 
and Y155 are in a very similar orientation and position to their DHDPS counterparts. 
Tryptophan is positioned in a similar position to the DHDPS tyrosine but its catalytic role in 


























The active site residues for E. coli DHDPS (blue) and P. fluorescens tHBPHA (red) are 
overlaid. Tyrosine, lysine and threonine of both DHDPS and tHBPHA are in similar 
orientations. The lysine of tHBPHA would point towards the other amino acids in 
presence of pyruvate. Y107 in DHDPS is replaced by W128 in tHBPHA. 
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2.2.5. Differential scanning fluorimetry to investigate substrate binding 
 
 
Differential scanning fluorimetry (DSF) was used on P. fluorescens tHBPHA proteins as well 
as E. coli DHDPS as a reference for a protein which will bind the substrates. Four conditions 
were used for each protein; Protein, protein in presence of Pyruvate, protein in presence of 
lysine and protein in presence of both lysine and pyruvate. This experiment is used to 
determine the relative melting points of each protein as well all to determine if the 
presence of each substrate could affect the melting points of each protein.  
 
E. coli DHDPS (a) showed an initial Tm of 60.82⁰C, this increased to 62.74⁰C with incubation 
in pyruvate, 65.12⁰C with lysine and 66.44⁰C with incubation of both substrates. For 
P.fluorescens tHBPHA (b), the relative melt points (Tm) for the protein was 51.23⁰C, this 
increased to 51.88⁰C with addition of pyruvate, 50.86⁰C with incubation with lysine and 
52.14⁰C when incubated with both. The result shows a slight increase in the melting 
temperature of the protein which suggests that binding of substrate could be occurring. If 














Thermal shift assay to examine the ability for tHBPHA to bind substrates related to the DHDPS.  P. 
fluorescens tHBPHA (a) and E. coli DHDPS (b). There is no significant change with the addition of 




2.2.6. Kinetic assay for DHDPS activity 
 
To investigate if tHBPHA capable of acting in place of DHDPS to catalyse the first step of the DAP 
pathway, a kinetic assay for DHDPS activity was investigated. Due to the sequence similarities 
between tHBPHA and DHDPS as well as the similarities within the active site, a DHDPS kinetic assay 
was formed using tHBPHA in place of DHDPS. There was no significant activity of tHBPHA when 
added into the DHDPS assay. This suggests that tHBPHA is unable to catalyse the DHDPS.  
 
2.3. Discussion and Conclusion 
 
The purifications of the two different tHBPHA proteins had mixed results due to the 
variation between protein yields from the two proteins. tHBPHA from P. fluorescens 
produced high yields of proteins during purifications (~30 mg or more of protein per 
purification from 1.6L of media) while tHBPHA from S. xenophagumi showed far lower yields 
(2-5 mg per purification from 1.6L of media). This resulted in difficulties in examining S. 
xenophagumi tHBPHA due to the large differences in protein present while P. fluorescens 
tHBPHA was able to be well characterised.  
 
Another tHBPHA was to be examined within this thesis but the yield and purity produced 
was too low to be accurately produce useful data from analytical techniques. The quality of 
S. xenophagumi tHBPHA was also lower than that of P. fluorescens, resulting in a higher 
level of difficulty to obtain similar results.  
 
One challenge in obtaining the crystal structure of tHBPHA is due to the lack of a compatible 
molecular replacement model due to a low sequence identity between other solved 
structures and tHBPHA. In spite of DHDPS and NAL having numerous solved structures, 
there are currently a lack of solved structures for tHBPHA. The closest sequence identity to 
P. fluorescens tHBPHA was: DHDPS from Acinetobacter baumannii at 31.36% identity, 
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DHDPS from Pseudomonas aeruginosa 27.98% identity and DHDPS from Legionella 
pneumophila 28.47% identity (Altschul, Madden et al. 1997, Altschul, Wootton et al. 2005). 
These proteins were analysed using PHENIX (Afonine, Grosse-Kunstleve et al. 2012) to 
attempt molecular replacement but were unsuccessful because of this low identity.  
 
With the production of a suitable model through Buccaneer, the P. fluorescens tHBPHA 
crystal was able to be solved through use of molecular replacement. If this wasn’t the case 
then the structure would, likely, have to be solved through production of Selenomethionine 
crystals in order to solve the structure through use of multi-wavelength anomalous 
diffraction (MAD) measurements (Wu, Lustbader et al. 1994). With a suitable model for 
molecular replacement being produced, the crystal structure could then be solved. 
Refinement was able to bring the initial R-free from 0.38 to 0.235.  
 
 
2.3.1. tHBPHA is in a tetrameric protein 
 
As was previously described in (Kuhm, Knackmuss et al. 1993), tHBPHA showed the 
possibility to exist as a trimer within solution. This would represent a novel member of the 
DHDPS/NAL subfamily of proteins which mostly exist with a tetrameric or dimeric 
orientation. To investigate the possibility of these proteins existing as a timer, AUC 
sedimentation velocity was used to determine the oligomeric state and the molecular 
weights of the tHBPHA proteins.  
 
The AUC data shows tHBPHA from both P. fluorescens and S. xenophagum sedimentating in 
a similar way to that of E .coli DHDPS as shown in figure 8. The similar sedimentation 
suggests that all three proteins share a similar weight and shape. This is shown with tHBPHA 
from P. fluorescens showing a sedimentation value of 7.0 S and S. xenophagum showing a 
sedimentation value of 7.1 S. Both values are similar to the sedimentation value of E. coli 
DHDPS at 7.25 S. The similarities between these proteins suggested that they sediment in a 
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similar way which is likely the result of sharing a similar size and orientation. When the 
molecular mass was calculated, it further showed that tHBPHA was consistent with a 
tetrameric mass of about 147.6 kDa for P. fluorescens tHBPHA and 145.6 kDa for S. 
xenophagum tHBPHA. These weights are consistent with a tetramer and far out weight the 
mass of what the theoretical trimer is.  
 
There was the slight presence of a secondary species which could have shown a 
dimeric/trimeric mass. The possibility that the oligomeric state of tHBPHA could be based on 
the concentration of protein was also investigated with (figure 9) which aimed to confirm if 
a change in oligomeric state was due to different protein concentrations. All three different 
concentrations show the same sedimentation value with no change anywhere else being 
noted. This shows that the tetrameric orientation of tHBPHA is constant and not based on 
the concentration of protein present.  
 
To further prove the presence of a tetrameric protein, SAXS was performed to investigate 
the solution structure. It allows for the validation of AUC results as well as providing a way 
to also confirm the crystal structure is similar to the structure within solution. Both tHBPHA 
proteins produced a well organised Kratky plot showing the presence of folded, globular 
proteins in solution. The intensity plots were also very similar for both the tetrameric E. coli 
DHDPS/NAL and tHBPHA proteins. This suggests that the tetrameric references and tHBPHA 
are similar. This is further shown with similarities in the p(r) plots. SAXS estimated that the 
molecular weight of P. fluorescens tHBPHA is 141.2 kDa, this value is similar to the one 
produced from AUC (147.6 kDa) further proving the presence of a tetrameric tHBPHA. 
 
This result is less consistent for S. xenophagum tHBPHA when compared to the molecular 
weights produce from AUC. AUC estimated the molecular mass to be about 145.6 kDa while 
SAXS calculated the weight to be 126.4 kDa. This value is slightly closer to the theoretical 
tetrameric structure than the trimeric structure. When coupled with the calculated mass 
from AUC, it suggests that S. xenophagum tHBPHA should be in a tetrameric orientation. 
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This result is similar to the one obtained from (Kuhm, Knackmuss et al. 1993) who predicted 
the presence of a trimeric protein. Their prediction of a weight close to 120 kDa is consistent 
to the SAXS result but is contrasted by the AUC result. While the S. xenophagum tHBPHA 
molecular weight could be interpreted as either trimeric or tetrameric, the P. fluorescens 
tHBPHA is a confirmed tetramer. 
 
The P. fluorescens tHBPHA was shown in a tetrameric orientation similar to DHDPS and NAL. 
Through prediction of the theoretical scatter from the crystal structure and comparison to 
the SAXS scatter, the authenticity of the crystal structures state can be determined. The chi2 
value from the tetrameric graph is 0.215 which is significantly lower than the dimeric value 
of 62.667. These values show a clear difference which results in the tetrameric orientation 
being present in solution over a dimeric one, resulting in the tetrameric crystal structure 
showing the correct orientation. The crystal structure was also unable to be solved in a 
trimeric orientation, further showing that the tetrameric orientation is correct.  
 
 
2.3.2. tHBPHA is similar to members of the DHDPS/NAL subfamily 
 
The previous work has shown that tHBPHA from both P. fluorescens and S. xenophagum 
exist in a tetrameric orientation. This has shown that the previous work by (Kuhm, 
Knackmuss et al. 1993) who reported a trimeric tHBPHA was inaccurate due the gel results. 
While a trimeric orientation would be an interesting structure for a member of the 
DHDPS/NAL subfamily due to their need to be present in a dimeric orientation for enzymatic 
activity, it has been shown that a tetramer is present. The oligomeric state and the presence 
of the TIM barrel fold resulted in an overall structure which is conserved through this 
subfamily.   
 
With the solved crystal structure of P.fluorescens tHBPHA, the similarities between tHBPHA 
and DHDPS / NAL can be clearly seen. Members of the DHDPS sub family all share the 
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characteristic TIM barrel fold. Figure 19 showed P. fluorescens tHBPHA aligned with the E. 
coli DHDPS. The conserved amino acids were in similar orientations to DHDPS, which 
suggested the mechanism of catalysis would follow a similar route. One interesting point is 
the difference between E. coli DHDPS and tHBPHA from P. fluorescens. The only major 
difference between DHDPS and tHBPHA being the tyrosine from the opposite monomer in 
DHDPS being replaced with a tryptophan in tHBPHA. How tHBP would bind within the active 
site with regards to the presence of the tryptophan within the active site is a possible point 
in which future investigation could take place. 
 
2.3.3. DHDPS activity from tHBPHA? 
 
Previous characterisation of tHBPHA from P. uesicularis included some kinetic analysis of 
tHBPHA(Kuhm, Knackmuss et al. 1993). Another found that tHBPHA was able to recognise a 
number of different substrates which varied on levels of similarity to the original substrate 
(Sello and Di Gennaro 2013). This shows the possibility for tHBPHA to promiscuously act in 
the DHDPS reaction due to its ability to catalyse different substrates and therefor showing a 
possibility to catalyse the DHDPS reaction. This thesis investigated the possibility of tHBPHA 
exhibiting DHDPS activity through use of a DHDPS kinetic assay as well as DSF to determine 
possible substrate binding.  
 
First, the use of DSF to determine if pyruvate and lysine were binding to tHBPHA. There was 
no significant change in the melting point of tHBPHA with the addition of pyruvate or lysine. 
There was a slight increase with each addition but the increase doesn’t seem significant 
when compared to the large increase from DHDPS.  
 
A DHDPS assay was performed to test the DHDPS activity of tHBPHA from P. fluorescens. It 
was determined that there was no significant activity from tHBPHA. This shows that tHBPHA 
is unable to perform a role as a promiscuous enzyme and participate in both pathways. It 
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was speculated that the presence of tryptophan could have performed the role of tyrosine 
similar to how a phenylalanine mutant did for DHDPS, but that doesn’t seem to be the case.  
 
2.3.4. Conclusion  
 
tHBPHA is a tetrameric protein as determined through multiple techniques. AUC 
determined that both tHBPHA proteins from P. fluorescens and S. xenophagum are in a 
tetrameric orientation due to the sedimentation coefficients being similar to the tetrameric 
DHDPS as well as the molecular weights determine from AUC corresponding with a 
tetrameric protein. SAXS performed on the tHBPHA proteins suggest that the proteins are in 
a tetrameric orientation. The tetrameric orientation is proven through the solution 
structures molecular weights which are calculated through the porod volumes produced 
from each protein through SAXS. S. xenophagum tHBPHA showed an odd molecular weight 
value from SAXS which was in-between tetramer and trimer.  
 
The crystal structure produced for tHBPHA from P. fluorescens also shows the tetrameric 
orientation is present. This is shown with a comparison of the theoretical x-ray scatter 
produced from a dimeric and a tetrameric tHBPHA crystal structure and their comparison to 
the SAXS solution scatter. The tetrameric structure showed a much higher correlation to the 
solution scatter than the dimeric structure and concludes, again, the presence of a 
tetrameric structure. The active site is similar to DHDPS with T65, Y155 and K183 being 
present in DHDPS by W128 replaces Y107. 
 
The possibility of DHDPS activity was investigated through a DHDPS assay as well and DSF to 
see if substrate binding took place. The kinetic assaying didn’t show any DHDPS activity 
taking place for tHBPHA, this could be due to protein being catalytically inactive. DSF 
showed both proteins were binding to pyruvate which is expected due to it being a known 
substrate involved in the tHBPHA reaction.   
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3.    Chapter three: What’s the Hype about HypD? 
 
3.1. Introduction into the Chapter 
 
The protein of interest in this chapter is another members of the DHDPS/NAL subfamily, 
HypD (Δ1-Pyrroline-4-hydroxy-2-carboxylate Deaminase or Pyr4H2C). This is a protein 
involved is involved in the degradation of L-hydroxyproline in bacteria. Four proteins will be 
structurally characterised within this chapter in order to determine the functional 
oligomeric state with a crystal structure being produced for M. lupine HypD.  
 
3.1.1. Δ1-Pyrroline-4-hydroxy-2-carboxylate Deaminase (HypD) 
 
3.1.1.1. The HypD Enzymatic Pathway 
 
L-Hydroxyproline mainly exists in collagen and within the cell wall of both plants and algae 
(Shibasaki, Mori et al. 1999). Its metabolism has been widely studied for mammals, involving 
a stepwise metabolism pathway that involves use of four different mitochondrial enzymes 
to produce the final products of pyruvate and glyocylate from a reaction with HOG aldolase 
(EC 4.1.3.16) (another member of the DHDPS/NAL subfamily (Riedel, Johnson et al. 2011). A 
similar pathway also takes place for L-proline, which results in the production of α-
ketogltarate.  
 
L-Hydroxyproline acts as a non-useable amino acid for a majority of microorganisms but few 
can metabolise and survive on L-hydroxyproline as a carbon source (eg Pseudomonas 
putida)(Gryder and Adams 1969). The microbial pathway is different from than found in 
mammals, first involving L-hydroxyproline epimerization into D-hydroxyproline and 
subsequent oxidation into Δ1-pyrroline-4-hydroxy-2-carboxylate (figure 21). This product 
then undergoes spontaneous hydrolysation into 4-hydroxy-2-oxo-5-aminovalerate. This is 
the substrate for HypD (Pyr4H2C). HypD then performs a deamination to form α-
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ketoglutaricsemialdehyde, which then undergoes a NADP+ dependent dehydrogenation into 
the final product α-ketoglutarate, a molecule involved as an intermediate in the Krebs cycle 
















3.1.1.2. Past Studies Investigating HypD  
 
One study investigated HypD from P. putida and P. aeruginosai and found that the two 
HypD proteins from these bacteria belong to the DHDPS/NAL subfamily of aldolase proteins. 
They examined the DHDPS activity and found that pyruvate was acting as an inhibitor 
(Watanabe, Morimoto et al. 2012). Because HypD shares the conserved lysine, which is 
involved in binding of pyruvate in most DHDHPS like proteins, its presence could act to bind 





The reaction of HypD proteins is shown from the metabolic pathway of L-hydroxyproline. 
Δ1-pyrroline-4-hydroxy-2-carboxylate is produced from the pathway and is undergoes 
spontainously Hydrolysation into 4-hydroxy-2-oxo-5-aminovalerate. HypD catalyses the 
deamination into α-ketoglutaricsemialdehyde (Watanabe, Kodaki et al. 2006, 
Watanabe, Yamada et al. 2007). 
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Another paper investigated a HypD protein from S. meliloti and have produced a crystal 
structure. They were able to structurally characterise a protein which was found to be 
within the DHDPS/NAL subfamily of proteins and exhibited the (α/β)8 TIM barrel fold. They 
reported that “The asymmetric unit of the solved structure is two monomers, and putative 
protein-protein interfaces suggested the formation of a homotetramer” (Chen, White et al. 
2016)  
 
3.1.2. Similarities to the DHDPS/NAL Subfamily 
3.1.2.1. Sequence alignment of Related Proteins. 
 
As with the previous chapter: the four HypD proteins examined within this thesis were 
subject to sequence alignment with other members of the DHDPS/NAL subfamily of proteins 
(figure 22). The sequence alignment is between: B. melitensis HypD, A. tumefaciens HypD, S. 
meliloti HypD, M. lupini HypD, E. coli DHDPS, E. coli NAL, P. aeruginosa DHDPS and H. sapien HOGA. 
Here we see some differences between the conserved residues of the active site between 
the reference proteins for this subfamily (E. coli DHDPS/NAL) the target proteins (the four 
HypD) and human HOGA protein (which reacts in a similar pathway from mammals (Riedel, 
Johnson et al. 2011)) 
 
The highly conserved lysine is present in the active site of the HypD proteins along with 
tyrosine which is also conserved through all members shown. These are the only two 
conserved amino acids within the active site for the HypD proteins. This suggests the 
catalytic mechanism could be significantly different to the other DHDPS like proteins. This is 
because there is no residue which corresponds to the Y107 in E. coli DHDPS which protrudes 
from the opposite monomer. This suggests that the active site architecture could be 
significantly different to other members of this subfamily. There are also no residues 
corresponding to T44 from E. coli DHDPS in the HypD structure but serine is conserved 
within this position for the other proteins in this alignment. This serine is likely interact in a 




























This figure shows the sequence alignments of some subfamily against the four HypD proteins. This figure shows: B. 
melitensis HypD, A. tumefaciens HypD, S. meliloti HypD, M. lupini HypD, E. coli DHDPS, E .coli NAL, P. aeruginosa DHDPS and 
H. sapien HOGA. This alignment is displayed using escript3.0 software (Robert and Gouet 2014) with secondary structure of 
B. melitensis HypD being shown along the top. Residues that are conserved throughout are in bold red while similar amino 
acids are in a blue box. There are a number of conserved residues throughout, in particular lysine and tyrosine which align 





(Watanabe et al) investigated the HypD proteins and determined that HypD might be in the 
DHDPS/NAL subfamily. Due to the conserved lysine and tyrosine residues this seemed to be 
the case, although HypD proteins don’t react with pyruvate which is a norm for members of 
this subfamily (Watanabe, Morimoto et al. 2012). HypD seem to share a common ancestor 
to other members to the DHDPS/NAL subfamily but have evolved in a different way as 
shown with the likely difference in catalytic mechanism.  
 
3.1.2.2. Crystal structure comparison of HypD to E. coli DHDPS 
 
The crystal structure of S. meliloti HypD (5CZJ) is shown in its reported tetrameric 
orientation (figure 23 a)). This protein exhibits the standard TIM barrel fold that is found 
within the DHDPS/NAL subfamily. The interesting point is that the two dimers are slightly 
angled, resulting in formation of a gap in the structure. When compared to the tetrameric 
structure of E. coli DHDPS (figure 23 b)), the presence of the gap shown with S. meliloti 
HypD is absent. This gap could be large enough to allow for a third dimer to fit, resulting in a 
hexameric protein. Figure 23 c) shows the A. tumefaciens HypD (2HMC) in such a hexameric 
orientation. The third dimer is present at the rear of the protein where the gap in the S. 




































The tetrameric structure of S. meliloti HypD (5CZJ) as proposed by (chen et al) (a) compared to E. coli 
DHDPS (1YXC)(b). The α-helices are coloured red and β-sheets are coloured in yellow both proteins 
show a face on view (left) and a 90⁰ rotation to show the side of the tetramer. S. meliloti HypD shows a 
large space when rotated compared to the lack of any space in DHDPS. The hexameric structure of A. 
tumefaciens HypD (2HMC) is shown (c). This structure shows the standard TIM barrel fold of the 








3.1.3. Aims for this chapter 
 
The aim of this chapter is to investigate the structural characteristics of HypD. This will 
revolve around the determination of the oligomeric state of HypD through use of AUC 
and SAXS techniques to investigate the HypD from the previously characterised A. 
tumefaciens, S. meliloti and B. melitensis HypD. These proteins have been previously 
characterised, but the determined oligomeric states have been inconsistent due to 
different groups reporting HypD as a tetramer or hexamer. Finally a previously 
uncharacterised HypD (M. lupine) will be structurally characterised in this chapter. The 




3.2.1. Purification of the HypD proteins 
 
The protein purified through his tag chromatography, with overnight TEV incubation 
followed by SEC chromatography to remove any TEV, his tag or aggregated protein. All HypD 
proteins had a high yield. S. meliloti and B. melitensis HypD produced about 30-40 mg/ml of 
protein from 1. 6L of media. A. tumefaciens and M. lupine HypD produced about 20-30 
mg/ml from 1.6 L of media. The yields were comparable to the yields of E. coli DHDPS, E. coli 
NAL and P. fluorescens tHBPHA purified previously.  
 
3.2.2. Analytical ultracentrifugation of HypD proteins 
 
The first aim was to determine the oligomeric states of the four HypD proteins, which was 
first investigated through use of AUC. The four HypD proteins were analysed using E. coli 
DHDPS as a reference for a tetrameric protein. This aims to determine if the proteins are in 
a tetrameric or hexameric state. All HypD proteins were at a concentration of 0.5 mg/ml and 
50 
 
E. coli DHDPS from the previous chapter (was used as a tetrameric reference) was at 0.5 
mg/ml. Each protein was showing a reading of about 0.5 at 280 nm. 
 
3.2.2.1. Sedimentation of HypD proteins compared to E. coli DHDPS 
 
The four HypD proteins show a significant difference in sedimentation coefficients.  The 
previously described sedimentation of the tetrameric DHDPS was 7.25 S. The results for the 
AUC for the HypD proteins are shown with figure 24. The HypD proteins produced 
sedimentation values of:  A. tumefaciens 9.6 S, S. meliloti 9.2 S, B. melitensis 9.4 S, M. lupine 
9.4 S. The sedimentation of the HypD proteins is compared with that of E. coli DHDPS. This 
shows that the sedimentation of HypD is significantly different to that of E. coli DHDPS. 
Because the large difference between the tetrameric DHDPS and the HypD proteins it 
suggests that the HypD proteins are far larger than DHDPS. There are no other species 














The sedimentation coefficients of the four HypD proteins were analysed using AUC sedimentation 
velocity. The sedimentation values were: B. melitensis at 9.6 S, A. tumefaciens at 9.2 S. meliloti at 9.4 
S and M. lupine at 9.4 S. All four HypD proteins show a consistent sedimentation with no obvious 
other species present within solution as well as a significant difference in sedimentation when 
competed to DHDPS 
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3.2.2.2. Integrated Mass of HypD Proteins  
 
The molecular mass of the four HypD proteins was also determined using AUC 
sedimentation velocity. As with the previous tHBPHA chapter, after determining the 
molecular mass from AUC the oligomeric state can be determined based on the molecular 
mass of the protein sequence. Because there is only one species present from the HypD 
proteins, calculation of molecular  
B. melitensis HypD shows the presence of a hexameric protein. It shows a theoretical 
monomeric weight of about 36.6 kDa based on the sequence. This produces a theoretical 
tetrameric weight of 142.4 kDa and a theoretical hexameric weight of 213.7 kDa. AUC 
estimated the molecular mass to be about 205 kDa. This value is significantly closer to that 
of a hexameric protein than a tetrameric one showing that B. melitensis HypD is in a 
hexameric orientation.  
A. tumefaciens HypD has a sequence weight of 34.4 kDa which results in a tetrameric weight 
of 137.8 kDa or hexameric weight of 206.7 kDa. AUC estimated the molecular mass to be 
about 202.4 kDa. This weight is consistent with that of a hexameric weight, not a tetrameric 
weight.  
S. meliloti HypD has a sequence weight of 34.4 kDa, resulting in a theoretical tetrameric 
weight of 137.8 kDa and a theoretical hexameric weight of 203.7 kDa. AUC estimated that 
the molecular mass to be about 198.3 kDa. This weight is consistent with that of a 
hexameric protein as opposed to that of a tetrameric one.  This contrasts what (Chen, White 
et al. 2016) reported when they discovered a tetrameric HypD from S. meliloti (Chen, White 
et al. 2016). 
Finally, M. lupine HypD has a sequence weight of 34.3 kDa, resulting in a theoretical 
tetrameric weight of 137.3 kDa or a theoretical hexameric weight of 206 kDa. The calculated 
molecular mass from AUC was 209.6 kDa. This is, again, consistent with that of a hexameric 
protein and not a tetrameric one. 
The calculated molecular mass from AUC are all consistent with hexameric proteins, 
showing that HypD proteins are hexameric in solution. Because there was no other species 
52 
 




























The molecular weights of the four HypD proteins were calculated using AUC sedimentation velocity. The 
calculated molecular mass was: B. melitensis at 205kDa (a), A. tumefaciens at 202.4kDa (b), S. meliloti at 
202.4kDa (c) and M. lupine of 209.6kDa (d). All of the HypD proteins showed molecular weight values which are 
consistent with hexameric proteins.    
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3.2.3. Small angle x-ray scattering 
 
In order to investigate the solution structures of the four HypD proteins, SAXS is used. All 
four HypD proteins are analysed using SAXS and the intensity data is plotted for B. 
melitensis, A. tumefaciens, S. meliloti and M. lupine (figure 26). These intensity plots show a 
high similarity, showing that the four HypD proteins share a similar form within solution.  
 
3.2.3.1. SAXS Intensity data 
 
The four intensity plots were normalised and aligned along with E. coli DHDPS. All four HypD 
protein share a very similar plot but contrast in shape to DHDPS. This suggests that the four 
HypD proteins aren’t in a tetrameric orientation and show a different shape to DHDPS.  
B. melitensis HypD shares a weight consistent with a hexameric protein. It produced a porod 
volume of 303427, with an I0 value of 0.12 and an Rg of 37.79. The molecular weight of 
4MPQ was probed with SAXS. Thig gave an estimated molecular weight of 205.7 kDa. The 
theoretical molecular weight of B. melitensis HypD, based of the original sequence, is a 
tetrameric weight of 142.5 kDa and a hexameric weight of 213.7 kDa. The closer molecular 
weight is closer to the theoretical hexameric weight suggesting that a hexameric orientation 
is present.  
A. tumefaciens HypD is consistent with a hexameric weight. It produced a porod volume of 
352273, with an I0 value of 0.17 and an Rg of 40.52. The theoretical molecular weight of the 
A. tumefaciens HypD tetramer is 148.3 kDa with a hexameric weight of 222.5 kDa. SAXS has 
estimated that he total molecular weight of about 237.7 kDa. This weight is about 15 kDa 
more than the theoretical hexameric weight and is significantly larger than the tetrameric 
weight.  
S. meliloti HypD is consistent with the weight of a hexameric protein. It produced a porod 
volume of 293859, with an I0 value of 0.18 and an Rg of 38.31. The theoretical molecular 
weight of the S. meliloti HypD tetramer is 137.8 kDa with a hexameric weight of 203.7 kDa. 
SAXS calculated that the weight of the solution structure was 211.6 kDa. This weight is 
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comparable to that of a hexameric protein, contrasting to a tetrameric protein as reported 
previously (Chen, White et al. 2016).  
The uncharacterised M. lupine HypD is consistent with the weight of a hexameric protein. It 
produced a porod volume of 303452, with an I0 value of 0.078 and an Rg of 39. The 
theoretical molecular weight of the M. lupine HypD monomer is 34.3kDa, resulting in a 
tetrameric weight of 137.3 kDa or a hexameric weight of 206 kDa. The SAXS experiment has 
estimated that the total molecular weight of the solution structure is 198.6 kDa. Which 
results in a monomeric weight of 33.1 kDa. This value is comparable, again, to the 


















The intensity plots produced from SAXS results.  They show the intensity plots of E.  coli 
DHDPS and four HypD proteins: B. melitensis, A. tumefaciens, S. meliloti, M. lupine. The 
intensity plots are aligned with DHDPS acting as a tetrameric reference. This figure 
showing that all four proteins are in a similar orientation within solution but different to 
the tetrameric reference. 
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3.2.3.2. p(r) Plots Showing a Difference between HypD and DHDPS 
 
With the exception of A. tumefaciens HypD, the HypD proteins show very similar molecular 
weights when compared to the theoretical hexameric weights. The four protein p(r) plots 
are aligned and normalised along with the p(r) plot of E. coli DHDPS (figure 27). All four 
protein show a similar p(r) distribution which is different from that of the tetrameric 
reference DHDPS, showing that the four HypD show a different presence in solution than E. 
coli DHDPS. This difference is likely due to the HypD proteins existing in a different 
conformation to DHDPS, due to the differences between the tetrameric DHDPS and 


















The p(r) data was calculated, using PRIMUS (Konarev, Volkov et al. 2003), for the four HypD proteins are plotted. 
This figure shows: B. melitensis HypD, A. tumefaciens HypD, S. meliloti HypD, M. lupine HypD. These plots are then 
normalised and aligned along with E. coli DHDPS as a tetrameric reference.  
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3.2.3.3. Kratky plots showing that HypD is a globular, folded protein. 
 
A Kratky plot was used to probe for protein folding. All four proteins show a similar Kratky 
plot with a single, uniform peak between 0-0.15 Å and scatter past 0.25 Å. This shows that 
























Four HypD shown with Kratky plots. The four plots show: B. melitensis HypD (a), A. tumefaciens HypD 
(b), S. meliloti HypD (c) and M. lupine HypD (d). All four proteins are folded within solution.  
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3.2.4. X-ray crystallographic study of M. lupine HypD 
 
Three of the four HypD proteins examined within this thesis have solved crystal structures. 
B. melitensis(4MPQ), A. tumefaciens(2hmc), S. meliloti(5CZJ) all have crystal structures on 
the pdb, this project was able to produce a M. lupine crystal structure to 2.9 Å. The protein 
was crystallised within the PACT suite within the numerous conditions, E4 (0.2 M Potassium 
thiocyanate, 20% (w/v) PEG 3350). The structure was solved using B. melitensis HypD as a 
molecular replacement model with the final structure showed an R-work value of 0.28 and an 
R-free value of 0.34. 
 
3.2.4.1. M. lupine HypD is A Hexameric Protein 
 
The monomeric structure of M. lupine HypD shows the characteristic TIM barrel fold similar 
to that of other members of the DHDPS/NAL subfamily (figure 29, a)). Eight β-sheets are 
present within the protein forming a pore. Eight α-helices surround the inner barrel with a 
further three helices present on one side.  
The crystal structure is shown in a hexameric orientation. (Figure 29, b)) Shows the 
hexameric orientation of M. lupine HypD. One way to describe the structure would be a 
comparison to a description of DHDPS. If DHDPS exists as a dimer of dimers then the 
observation of the HypD structure would be a trimer of dimers. The dimers also form a 
slight twist where the dimer-dimer interface meets, resulting in an angle which makes the 
dimers (curve). This contrasts to DHDPS which is more flat. Two monomers form an 
interface in a similar way to DHDPS and other members of the sub family. When two dimers 
come together within the crystal structure it somewhat resembles other DHDPS/NAL 
subfamily members but the presence of a large gap is also present as was shown in (figure 

































The crystal structure for M. lupine solved to 2.9 Å. The monomeric structure is 
shown (a) with α-helices coloured red, β-sheets in yellow and the remaining 
structure in green. This protein is shown to exist in a hexameric orientation and 




3.2.4.2. Comparison of theoretical crystal scatter to solution scatter 
 
The because all four proteins now have crystal structures produced form them, B. melitensis 
(4MPQ), A. tumefaciens (2hmc), S. meliloti (5CZJ) and M. lupine, the theoretical scatter 
generated from the crystal structures can be compared to the solution structure scatter 
from SAXS.  
The comparison between a tetrameric HypD protein (as was described in (Chen, White et al. 
2016) and a hexameric HypD is shown with Figure (figure 30). For B. melitensis (4MPQ), the 
tetrameric structure produced a chi2 value of 31.081 compared to a chi2 value of 0.535 for 
the hexameric structure. A. tumefaciens HypD (2HMC) produced a chi2 value of 93.099 for 
the tetrameric structure while producing a chi2 value of 2.559 for the hexameric structure. S. 
meliloti HypD (5CZJ) produced a chi2 for the tetrameric structure of 54.237 while the 
hexameric structure produced a chi2 value of 0.344. Finally, M. lupine HypD structure 
produced a chi2 value of 34.237 for the tetrameric structure and 3.569 for the hexameric 
structure.  
These chi2 values strongly suggest that the HypD crystal structure is most correct when in a 
hexameric orientation. The significant differences between the tetrameric chi2 values and 
the hexameric chi2 values show that a hexameric HypD is the correct orientation for the 







































The theoretical scatter from the four HypD crystal structures was compared to the SAXS scatter 
to determine which oligomeric state is correct. The four HypD proteins: B. melitensis 
HypD(4MPQ)(a), A. tumefaciens HypD(2HMC) (b), S. meliloti HypD(5CZJ) (c) and M. lupine 
HypD(d). Each shows the theoretical scatter of a tetrameric crystal (left) compared to the 
theoretical scatter from a hexameric crystal (right).  
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3.2.4.3. Comparison of the crystal structures of M. lupine and S. meliloti 
HypD 
 
The new crystal structure of M. lupine HypD and S. meliloti HypD are overlaid. Since S. 
meliloti HypD was previously reported as a tetramer, an overlay with the already confirmed 
hexameric M. lupine HypD would further confirm the presence of a hexamer through the 
architectural similarities. (figure 31, a)) Shows the monomeric alignment of the two proteins 
showing a high similarity. M. lupine HypD (green) shows a high similarity to the structure of 
S. meliloti HypD, this should be expected due to both being HypD proteins and sharing 
about an 81.5% sequence identity. The similarities are further confirmed when the two 
hexameric HypD are aligned as shown in (figure 31, b)). M. lupine HypD and S. meliloti HypD 
show a very similar hexameric orientation which only slight variation. This further confirms 
















The monomeric crystal structures of the S. meliloti (red) and M. lupine (green) HypD are aligned to show 
the similarity between the two (a). The hexameric structure of M. lupine HypD is then aligned to the 






3.2.4.3.1. Active site of B. melitensis HypD and possible mechanism 
 
The catalytic mechanism for HypD proteins is unknown due to lack of structures solved 
bound to substrate. Figure 31 shows the active site of B. melitensis HypD with the residues 
that are conserved with members of the DHDPS/NAL subfamily are shown in yellow (K164, 
and Y136) and residues surrounding these possible key amino acids in cyan. Me102 is also 
positioned near the conserved lysine and tyrosine. A possible interaction could occur. One 
point that contrasts with other members of the subfamily is that there doesn’t seem to be 
any involvement from the opposite dimer within the active site. This suggests that each 
monomer can individually catalyse the reaction. S48 is in a similar position to serine found 
the NAL active site, this suggests that it could operate in a similar way. K 164 is almost 
certainly involved in Schiff base formation with the substrate, this is due to the similar 
mechanism present in all other members of the DHDPS/NAL subfamily. Because there hasn’t 















The active site of B. melitensis HypD (4MPQ) is examined. Amino acids which are identified through 
sequence alignments are coloured yellow with other residues possibly involved in catalysis are coloured 
cyan. The conserved residues of K173 and Y145 are present in HypD and other members of the 







3.2.4.3.2. Overlay of B. melitensis HypD with E. coli DHDPS 
 
The monomers of DHDPS and HypD share a similar structure due to the TIM barrel fold but 
are slightly different. The monomers of E. coli DHDPS (red) and B. melitensis HypD (blue) are 
aligned (Figure 32). They both share the same fold but the DHDPS shows a ‘tighter’ structure 
when compared to HypD. The DHDPS structure’s coils seem to be more compact than that 
of HypD, resulting in a slightly smaller monomer. The HypD monomer α-helices seem to be 



















The alignment of E. coli DHDPS (red) and B. melitensis HypD (blue). Both share a similar fold, DHDPS 
seems to show a tighter arrangement of the secondary structure when compared to HypD.  
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3.2.5. Kinetic Assay for DHDPS Activity 
 
S. meliloti and M. lupine were added in place of DHDPS in a DHDPS assay in order to 
determine if there was any DHDPS activity for both proteins. The kinetics showed that there 
was not any significant activity for either S. meliloti or M. lupine, concluding that, while both 
are within the same subfamily and share structural similarities, they don’t exhibit the ability 
to catalyse a DHDPS reaction.  
 
 
3.3. Discussion and Conclusion 
 
3.3.1. HypD are hexameric proteins within solution 
 
Initial AUC readings show that the way HypD sediments is significantly different to that of E. 
coli DHDPS. This is shown with (Figure 24) where the all four HypD proteins share a similar 
sedimentation coefficient ranging between 9.2 S and 9.6 S. When compared to the 
sedimentation vale of E. coli DHDPS or even the tHBPHA proteins of 7.1 S-7.3 S. This data 
suggests that the four HypD sediment with solution in a different way to the other 
tetrameric proteins within the DHDPS/NAL subfamily. One possibility for this is the presence 
of a hexameric protein. There is also a distinct lack of any secondary peaks on the 
sedimentation graph, showing that the possibility for two different oligomeric states based 
on concentration is unlikely. This difference is further seen when the AUC s(M) data is 
analysed, showing that the four HypD proteins investigated showing molecular mass of 
about 200 kDa, again consistent with hexameric proteins. 
 
AUC has shown that the HypD proteins are unlikely to be tetrameric proteins, this is further 
confirmed through SAXS. SAXS estimated the solution molecular weights for all the HypD 
proteins and found that the weights were significantly larger than the theoretical tetrameric 
weights while being very similar to the theoretical hexameric weight. The intensity plots and 
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p(r) plots also show a noticeable difference when comparing the HypD proteins to their 
tetrameric subfamily members.  
 
S. meliloti HypD is in a hexameric orientation which contrasts to what was reported 
previously by (Chen, White et al. 2016). The crystal structures of the Four HypD proteins are 
more comparable to the solution structures than their tetrameric orientations. This is shown 
with (figure 29) further showing the presence of the hexameric proteins.  
 
The study that characterised S. meliloti HypD as a tetrameric protein likely only observed 
the monomer / dimer crystal structure and concluded the presence of a tetrameric protein 
without investigating this claim. When the S. meliloti HypD crystal structure (5CZJ) was 
compared to the new M. lupine HypD crystal structure, the similarities in the monomeric 
and hexameric orientations further show that S. meliloti HypD is hexameric.  
 
Whether HypD proteins evolved into a hexameric protein from a tetrameric origin or was 
originally a hexamer is unknown. It is speculation that the HypD protein has possibly evolved 
from a tetrameric protein. Because it is within the DHDPS/NAL subfamily where a tetrameric 
orientation is a relative norm, there is some credibility in the possibility of a tetrameric 
origin, the catalytic significance of this hexameric protein could be investigated in future to 
demine the catalytic activity: firstly, of the HypD proteins towards their intended reaction 
and secondly, the effect of mutations resulting in a tetrameric or even dimeric/ monomeric 
protein.  
 
3.3.2. HypD is a novel member of the DHDPS/NAL subfamily 
 
HypD proteins are present in the DHDPS/NAL subfamily of proteins with the TIM barrel fold 
but is a novel member of this family. It is hexameric in a subfamily where the standard 
protein is in a tetrameric orientation. HypD also doesn’t share the similar chemistry 
involving pyruvate.  Most DHDPS are in a tetrameric orientation and mutations effecting the 
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oligomeric state negatively impact the enzymatic activity (Pearce, Dobson et al. 2008) while 
the hexameric HypD have added a unique touch to this subfamily.  
 
The sequence alignment (figure 22) showed that there are certain differences between the 
active sties of the HypD proteins and other members of the DHDPS/NAL subfamily of 
proteins. The alignment showed that threonine was replaced with serine in HypD and that 
the second tyrosine in DHDPS (and tryptophan in tHBPHA) was replaced with valine and 
wasn’t present in the active site. The lack of a similar amino acid in the position suggests 
there is no interaction between the opposing monomer. Showing that the catalytic 
mechanism of HypD should different to other subfamily members. There is still the highly 
conserved lysine present within the HypD active site which would result in binding and 
Schiff base formation with HypD’s substrate. The serine residue is in a similar position to 
that of the serine in the NAL active site. It is positioned in a location where the substrate 
could bind within. The lack of an interaction between monomers is different from the other 
(known) subfamily members.  
 
This speculation is due to the differences in the active site architecture where the monomer. 
As reported in (Watanabe et al), HypD proteins seem to share a common ancestor inspite 
not involving pyruvate (based in a phylogentetic tree)(Watanabe, Morimoto et al. 2012). 
HOG aldolaste is another member of the DHDPS/NAL subfamily which is involved in 
mamanlian L-Hydroxyproline metabolism but does involve a reactoin where pyruvate is the 
product(Watanabe, Kodaki et al. 2006, Watanabe, Yamada et al. 2007). The possibility of 
divergent prtoein evolutoin is a possiblitiy since with HypD retaining tyrosine and lysine 








3.3.3. DHDPS activity from HypD? 
 
As previously stated, the active site architecture of the HypD proteins suggest that DHDPS 
activity is unlikely. There is still the conserved lysine and tyrosine present in the active site 
but formation of a catalytic triad similar to DHDPS shouldn’t be possible. It was reported by 
Watanabe et al), that pyruvate inhibited HypD, this could be due to pyruvate binding within 
the active site to the conserved lysine.  
 
The possibility for HypD to show DHDPS activity was investigated through use of a DHDPS 
assay. This was done in order to determine if HypD (a member of the DHDPS/NAL subfamily) 
could share on a catalytic similarity with DHDPS and catalyse its reaction. If it does express 
DHDPS activity then the possibility of HypD acting as another DHDPS could lead to problems 
for drugs that specifically target DHDPS for inhibition. 5CZJ and MICRO were assayed to 
investigate this possibility. There was no change in the absorbance measurements when the 
HypD were added into the assay. This shows that, while being a member of the DHDPS/NAL 




The four HypD proteins studied are seemingly in a hexameric orientation. AUC shows that 
the HypD sediment differently to a tetrameric reference in DHDPS. The SAXS intensity data 
contrasts between the HypD and DHDPS and estimated molecular weights of the HypD 
proteins are in line with hexameric proteins.  
The crystal structure of M. lupine HypD was solved to 2.9 Å, showing a hexameric 
orientation. The crystal structures theoretical scatter matched the solution scatter from 
SAXS when a hexameric structure is used which further showed this fact. DHDPS activity was 
assayed and found no significant activity, showing that HypD can’t act as a DHDPS in spite 




4. Chapter four: conclusions 
 
The DHDPS/NAL subfamily of proteins are a good group to observe protein evolution due to 
all proteins sharing a commonly conserved TIM barrel fold and catalyse similar reactions. 
The Subfamily contains a number of proteins from different catalytic pathways but catalyse 
similar reactions. Of these, DHDPS and NAL are well characterised while others remain 
vaguely characterised. This thesis aims to characterise some of the more obscure members of 





This project aims to structurally characterise two proteins from this subfamily, tHBPHA has 
previously been reported in a trimeric orientation (which is a direct contrast to other members 
of this subfamily) which could represent a novel member of this subfamily. HypD is another 
obscure member. Previously, HypD has been classed as a tetrameric protein or a hexameric 
protein. This thesis aims investigate the structural characteristics of these proteins as well as 
to determine the crystal structures in order to investigate the possibly different catalytic 
mechanisms. It also aims to investigate the possibility for these proteins to exhibit like 
DHDPS activity through use of a DHDPS kinetic assay.  
 
 
4.2. tHBPHA is tetrameric 
 
Through use of different analytical techniques, it was concluded that tHBPHA is a tetrameric 
protein. AUC showed that both P. fluorescens tHBPHA and S. xenophagum tHBPHA are 
consistant with tetrameric proteins. Their sedimentation coefficients are simmilar to that of 
the tetrameric reference E. coli DHDPS (7.0-7.3 S) as well as the calculated molecular mass 
being simmilar to the theoretical tetrameric value calculated from the sequence. With use of 
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SAXS this was further shown. The SAXS porod volumes for P. fluorescens tHBPHA further 
showed the presence of a tetrameric protein. 
The crystal structure for P. fluorescens tHBPHA was solved to 2.2 Å. The solved structure 
showed the TIM barrel fold which conserved throughout the other members of this 
subfamily. The tetrameric orientation is similar to other DHDPS proteins. The active site is 
highly conserved with the only active site residue not conserved from E. coli DHDPS (W128 
in tHBPHA) which replaces tyrosine. This residue could interact in a similar way to tyrosine 
with no crystal structures with substrate bound within the active site, the mechanism can only 
be speculation. To see if this similarity in the active site would result in DHDPS activity, P. 
fluorescens tHBPHA was assayed for DHDPS activity but there was no significant activity 
towards the DHDPS substrate.  
 
4.3. HypD is hexameric 
 
Inorder to determine which ologumeric state the HypD proteins, AUC sedimentation velocity 
was used. The HypD proteins showed a sedimentation coefficient signifigantly larger than the 
tetrameric reference of DHDPS, showing that HypD sediment different from tetrameric 
proteins. This was further shown when the molecular mass was calculated over 200 kDa for 
the four HypD proteins. This weight is consistant with the theoretical hexameric weight, 
showing the presence of hexameric proteins. Molecular weights calculated from SAXS porod 
volumes were also consistant with the hexameric proteins. when the theoreical scater from 
the crytsal structures were compare to the SAXS scatter, the result showed a higher 
correlation with a hexameric HypD than a tetrameric one.  
The crystal structure for M. lupine HypD was producd and solved to 2.9Å. HypD show the 
conserved TIM barrel fold present within the subfamily. One interesting point is tha the 
HypD proteins don’t seem to show any interactions with residues within the active site and 
residues from the opposing monomer in the dimer interface. They lack a tyrosine (in 
DHDPS/NAL) or even a tryphtophan (in tHBPHA) that potrudes into the active site. This 
suggests that the mechanism for HypD is different from the mechanism for other subfamily 
members. HypD still retains the highly conserved lysine, while its reaction doesn not invlovle 
pyruvate, the mechanism should still involve the use of this residue to form a schiff base 
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intermeidate with the substrate. The possiblity for HypD to catalyse the DHDPS reaction was 
investigated, there was no signifigant activity from HypD.  
 
4.4. Future research 
 
Since both P. fluorescens tHBPHA and the four HypD proteins are able to form crystal 
structures, they can be used to investigate these proteins catalytic activity. How the catalytic 
mechanism would progress will be dependent of these substrate studies. How does the 
tryptophan in tHPBHA interact with its substrate? Is it similar to how tyrosine in DHDPS 
functions? This is also true for HypD, because there is no interaction between the two 
monomers in the dimer interface, the catalytic mechanism should follow a different 
mechanism. How these different mechanisms fit in with the other members of this subfamily 

















5. Chapter five : methods and experimental 
5.1. Producing competent cells 
 
E. coli BL-21 (DE3) pLysS cells are streaked out on agar plates containing chloramphenicol 
antibiotic and incubated at 37⁰C overnight. A single colony was inoculated into a 5 ml LB (25 
g/L) culture with 5 µl chloramphenicol and incubated overnight. 100 µl was taken and 
incubated into a 100 ml flask of LB and incubated at 37⁰C on a shaker. When the A600 
reached ~0.8 A.U., the cells are transferred into autoclaved centrifuge bottles and stored on 
ice for 15 min. The cells are harvested by spinning in a centrifuge at 4000 rpm, 4⁰C for 10 
min. The cell pellet is gently resuspended in 20 ml of autoclaved CaCl2. The cells are again 
harvested by spinning in a centrifuge at 4000 rpm, 4⁰C for 10 min. The cell pellet is gently 
resuspended in 4ml of autoclaved CaCl2. 100 µl aliquots are stored in autoclaved Eppendorf 
tubes and flash frozen in liquid nitrogen for storage at -80⁰C.  
 
 
5.2. Transformations of desired proteins into BL 21 (DE3) cells 
 
All plasmids are ordered from Epoch life science and are stored within the -80⁰C freezer. A 
total of seven plasmids were ordered and transformed during this thesis. E. coli DHDPS and 
NAL plasmids were previously transformed into BL21 (DE3) pLysS cells and stored as a 
glycerol stock. All plasmids contained a His-tag and TEV cleavage region.  
 
Agar plates used to grow transformed cells was prepared by mixing LB (15 g/L) and agar (10 
g/L) and then autoclaved. The appropriate amount of chloramphenicol and kanamycin is 
added and the plates are poured onto trays in a sterile fume hood. Eppendorf’s containing 100 
µl competent cells are taken from the -80⁰C freezer and thawed on ice. 1 µl of the desired 
plasmid is added and incubated on ice for 40 min. Heat shock each transformation tube by 
placing the bottom 1/2 of the tube into a 42 °C water bath for 45 min. 1 ml of LB media is 
added and the cells incubated at 37⁰C on a shaking platform for 60 min. Transformed cells 
are harvested by spinning at 5000 rpm for 1 min, the remaining media is removed by 
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inverting the tube. The cells are resuspended in the remaining media. A control is prepared 
following the previous steps to ensure that the original cells cannot grow and only 
transformed cells can. The resuspended cells are then spread over the agar plates using a 
sterile plastic/glass spreader within a sterile fume hood. The cells are left for 10 min and then 
incubated at 37⁰C overnight. If the transformation has succeeded, the plates will show colony 
growth.  
 
5.3. Purification of proteins  
 
tHBPHA was purified from P. fluorescens and S. xenophagum . HypD protein was purified 
from: A. tumefaciens, S. meliloti, B. melitensis and M. lupine. This project involved purifying 
a number of proteins in order to investigate structural details as well as for adding reference 
points using already known structures.  E. coli DHDHPS and NAL were purified as a 
reference point for tetrameric proteins with E. coli DHDPS acting as a tetrameric reference 
for the tHBP-HA and HypD proteins. 
 
One colony from the transformed cell plates is selected and transferred into a 5 ml culture of 
LB containing 10 µl of chloramphenicol and kanamycin. This is incubated at 37⁰C on a 
shaking platform overnight. 1 ml of this culture will then be transferred into each large 
culture flask containing 800 ml of M9ZB media. These flasks will then be incubated at 37⁰C 
on a shaking platform. The cultures will be monitored until the A600 reaches ~0.8A.U. 800 µl 
of 1 mM IPTG will then be added to each flask with the flasks then being incubated at 25⁰C 
on a shaking platform overnight.  
 
M9ZB media 
Chemical Na2HPO4 NH4Cl KH2PO4 NaCl Bacto-tryptone Yeast extract 









After incubation cells are poured into 400 ml centrifuge tubes and harvested by spinning at 
8000 rpm for 8 min at 4⁰C. The cells are resuspended in 10 ml (per centrifuge tube) of His-
tag buffer a (50 mM Na2HPO4, 500 mM NaCl, 30 mM imidazole, pH 8). The resuspended 
cells are kept on ice and then sonicated using the UP200S (hielscher) for 20 min at 70% 
amplification with the cycle set to 0.5. The sonicated cells are then transferred into the small 
centrifuge tubes and spun at 15000 rpm for 15 min at 4⁰C. The supernatant is carefully 
collected in a 50 ml falcon tube to reduce the amount of the pelleted cellular debris being 
collected. While and kept on ice the crude protein is filtered through a .22-μm filter to 
remove large cellular debris that could be present in the crude solution. All proteins are 
purified through use of His-tag chromatography using the Akta.  The His-Trap HP, 5 x 5 ml 
(GE Life Science) was attached to the Akta and was equilibrated through washing initially 
with His-tag buffer B (50 mM Na2HPO4, 500 mM NaCl, 300 mM imidazole, pH 8) to 
remove anything that could be inside the column. His-tag buffer A is then flowed through 
until the UV reading stabilises. Crude protein is injected into the Akta along with His-tag 
buffer A and passed through the His-tag column. After all the crude has passed through, 
buffer is streamed until no crude remains within the column and only protein is attached 
within (as seen with the change in UV reading). His-tag buffer B is streamed through to elute 
the protein attached to the nickel within the column, the elution of protein is shown with a 










Chemical Na2HPO4 NaCl imidazole 
concentration  (mM) 50 500 30
Chemical Na2HPO4 NaCl imidazole 




His-tag Buffer formula for His-tag buffer A and his-tag buffer B. 
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The protein purified from His-tag chromatography is then passed through a desalt column to 
remove excess salt and imidazole present. The desalt column is a low resolution Size 
exclusion column which separates proteins from the smaller salt molecules. Tris buffer (150 
mM NaCl, 20 mM tris-HCl, pH 8) is streamed along with protein through the column. The 








The his-tag on the proteins is removed via TEV cleavage. Previously purified TEV protease 
will be incubated with a His-tagged protein post desalt. TEV protease is added at a ratio of 1 
mg of TEV to 100 mg of his tagged protein. Proteins can be further purified (to remove 
aggregate and TEV) through use of a 24 mL Superdex™ 200 10/300 gel filtration column 
(GE Healthcare). This is a 24 ml column that will separate different proteins based on their 
size as they pass through the column. The flow rate is set to 0.4-0.5 mL/min in order to 
reduce the pressure below 1.2 mPa. Tetrameric protein will elute from the colum at ~14 ml 
while hexameric protein will elute at ~12 ml. Any aggregate will be eluted at 10-12 ml. TEV 
will elute after the protein due to its smaller size. 
 
5.4. Purification of TEV protease 
 
TEV protease is used to cleave the His-tag off proteins. TEV protease was purified from 
stock cells possessing resistances for chloramphenicol and kanamycin. The cells were grown 
in M9ZB media, incubated at 37⁰C on a shaking platform until they reached an OD600 of 0.6-
0.8 A.U. They are then induced with addition of 1 mM IPTG and incubated on a shaking 
platform overnight at 25⁰C. 
Chemical NaCl tris-HCl
concentration  (mM) 150 20
tris-HCL  sotrage buffer
Table 3 
Tris-HCl Storage buffer. Proteins are stored at -80⁰C within this buffer as 




 After incubation cells are poured into 400 ml centrifuge tubes and harvested by spinning at 
8000 rpm for 8 min at 4⁰C. The cells are resuspended in 10 ml (per centrifuge tube) of TEV 
buffer A (50 mM Na2HPO4, 500 mM NaCl, 10 mM imidazole, 5% glycerol, pH 8.0).The 
resuspended cells are kept on ice and then sonicated using the UP200S (hielscher) for 20min 
at 70% amplification with the cycle set to 0.5. The sonicated cells are then transferred into the 
small centrifuge tubes and spun at 15000 rpm for 15 min at 4⁰C. TEV protease is then 
purified via his-tag chromatography using TEV buffer A and TEV buffer B (50 mM 
Na2HPO4, 500 mM NaCl, 500 mM imidazole, 5% glycerol, pH 8.0) in place of His-tag buffer 
A and his-tag buffer B respectively. After purification the protein is kept on ice and 
precipitated using ammonium sulphate to a concentration of 65% and is kept on ice for 15 
min. The solution is spun at 6000 rpm at 4⁰C for 10 min and the supernatant is discarded. The 
precipitated TEV is dissolved in TEV storage buffer (300 mM NaCl, 20 mM tris-HCl, 1 mM 
EDTA, 50% glycerol, pH 8.0). It is then distributed into 100 µl volumes in eppendorf tubes, 








Chemical Na2HPO4 NaCl imidazole glycerol
concentration  (mM) 50 500 10 5%
Chemical Na2HPO4 NaCl imidazole glycerol
concentration  (mM) 50 500 500 5%
Chemical NACL tris-HCl EDTA glycerol
concentration  (mM) 300 20 1 50%
TEV His-tag buffer B
TEV storage buffer
TEV His-tag buffer A
Table 4  
The formula for three TEV buffers for use in TEV purification.  
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5.5. Analytical Ultracentrifugation (AUC) 
 
AUC sedimentation velocity experiments are used to determine the molecular weight and 
oligomeric state of the protein samples. It involves using a pure protein sample that has 
passed through a 24 mL Superdex™ 200 10/300 gel filtration column (GE Healthcare) . The 
proteins were equilibrated to the tris buffer. 400 µl of tris buffer (used as a blank) and 380 µl 
of protein sample are loaded into the 12 mm double-sector cells with quartz windows in an 
eight hole (An-50) rotor. Once all samples are loaded, the rotor is inserted into the 
ProteomeLab XL-I (Beckman) analytical ultracentrifuge. The rotor is then equilibrated to 
20⁰C. The AUC was run at 50000 rpm at 20⁰C until 100 scans 285 nm using a UV/Vis 
scanning optics until completion. These process was carried out under supervision of Dr 
Grant Pearce.  
 
The concentrations of proteins analysed were: P.fluorescens tHBPHA 0.5 mg/ml, 
S.xenophagum tHBPHA 0.2 mg/ml, E. coli DHDPS 0.5mg/ml, B.melitensis HypD 0.4mg/ml, 
A.tumefaciens HypD 0.4 mg/ml, S.meliloti HypD 0.4 g/ml, M.lupine HypD 0.4 mg/ml. the 
final P.fluorescens tHBPHA was run at varying concentrations of : 0.1 mg/ml, 0.2 mg/ml and 
0.4 mg/ml. Data provided from the AUC is analysed using the SEDFIT program(Schuck 
2000).This program will run either a c(M) distribution to determine protein molecular mass 
or c(s) distribution to determine protein sedimentation coefficients. Buffer density is set to 
0.99823 g/ml and viscosity to 0.01002 g/L for the standard tris buffer the proteins are stored 
in, as calculated sednterp (T.M. Laue 1992). Data analysed with this program will be 
represented as graph of either protein sedimentation or protein molecular weight.   
 
5.6. Gel electrophoresis SDS-PAGE 
 
Protein SDS-PAGE was executed using premade gels. Each sample will contain 2.5 µl of 4X 
dye, 5-10 µg of protein (~1-6 µl depending on initial protein concentration) and the 
remaining MiliQ H2O to bring the total volume of the sample to at least 10µl. The samples 
are mixed be briefly using a benchtop centrifuge and incubated in a 70⁰C water bath for 5 
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min. The premade gel is inserted into the gel electrophoresis apparatus with MES buffer 
being poured to fill the apparatus. The samples are then pipetted into the different lanes with 
the addition of 5 μl of Novex® Sharp Pre-Stained Protein Standard (Invitrogen). The gel is 
run at 166 V for 35 min in 1X NuPAGE® MES SDS Running Buffer. The gel is then 
removed from the apparatus and its casing removed. The gel is rinsed in H2O and 
microwaved twice before being stained for 1 h in Simply Blue stain. The gel is then rinsed in 
H2O and de-stained overnight.  
 
5.7. Concentrating protein samples 
 
Protein samples are concentrated using Vivaspin 6, 30,000 MWCO PES concentrators from 
Sartorius Stedim Biotech. Protein is added into the tube and then sun in the centrifuge at 4000 
rpm at 4⁰C for 4-5 min per spin. The concentration of protein is determined using NanoDrop 
ND 1000 spectrophotometer from Thermo Scientific. If the protein concentration was not at 
the desired point, the process is repeated until the desired concentration is achieved.  
 
5.8. X-ray crystallography 
 
Protein to be used for crystallography is purified and run through the size exclusion column. 
It is then concentrated using Vivaspin 6, 30,000 MWCO PES concentrators, aiming to have 
the final concentration at about 10 mg/ml. The protein crystal screens are obtained using the 
JCSG+ and PACT suite screens (Molecular Dimensions). 96 well plates are filled with the 
screen conditions using a 12 channel pipette. Both trays and proteins are taken to the UC 
chemistry department. With a 50 µl stock protein sample was prepared at 10 mg/ml.  Use of 
Mosquito® Crystal automated liquid distributer (TTP Labtech) to distribute a 50 µl stock 
protein sample into 400 nL droplets. The trays are then sealed and carefully incubated in the 
desired conditions. tHBPHA was incubated at 20⁰C while HypD crystals were incubated 8⁰C 
and 25⁰C) to facilitate crystal growth. Each tray is examined for crystal formation using light 




The crystal trays with suitable crystals are sent to the Australian Synchrotron in order to 
collect diffraction data. The crystals are placed under a light microscope and the crystal is 
examined. The seal around the condition is cut with a scalpel and the crystal is extracted into 
a loop. This is quickly placed into cryoprotectant (1:1 mixture of ethylene glycol and 
glycerol) and submerged into a bowl of liquid nitrogen. This loop with the crystal is kept 
within the liquid nitrogen until it is attached within the beamline room under a cryo stream. 
The crystal is positioned directly in the path of the beam line. One the crystal is correctly 
positioned, the beamline is activated and x-rays are shot through the crystal, producing a 
diffraction pattern. This diffraction patters is analysed using CCP4 to produce a MTZ file 
with the diffraction data (Bailey 1994, McCoy, Grosse-Kunstleve et al. 2007).  
The structures in this thesis were solved through use of the Australian Synchrotron (Panjikar, 
Parthasarathy et al. 2005, Panjikar, Parthasarathy et al. 2009). THBPHA from P. fluorescens 
was solved using AUTO RIKSHAW. First the program Pirate (Cowtan 2000) was used to 
statistically modify the phase probability distributions to produce an improved version of the 
phase probability distributions. This was further modified using the program SHELXE for 
phase and density modifications (Sheldrick 2010). Because the sequence similarity of P. 
fluorescens tHBPHA was so low to other solved proteins, ordinary molecular replacement 
was unable to solve the structure. Through use of Buccaneer (Cowtan 2006, Cowtan 2008), a 
model was formed which was suitable for molecular replacement. Molecular replacement and 
subsequent structural refinement was carried out using PHENIX software (McCoy, Grosse-
Kunstleve et al. 2007, Afonine, Grosse-Kunstleve et al. 2012). The crystal structure was 
solved to 2.2Å, with an r-work value from 0.3 to 0.18 and a change in the r-free values of 
0.38 to 0.235. M. lupine had a high sequence similarity to other solved HypD structures and 
use of AUTO RICKSHAW was not needed. Again, the program PHENIX was used for the 
molecular replacement and refinements using the crystal structure of B. melitensis HypD 
(4MPQ) and a molecular replacement model (McCoy, Grosse-Kunstleve et al. 2007, Afonine, 
Grosse-Kunstleve et al. 2012). The crystal structure was solved to 2.9Å resolution producing 







5.9.  Small Angle X-ray Scattering 
 
Small Angle X-ray Scattering is a technique to probe the solution structures of proteins. All 
samples to be sent were run through a 24 mL Superdex™ 200 10/300 gel filtration column 
(GE Healthcare) to remove any aggregate. The samples are equilibrated into tris buffer and 
are concentrated above 5 mg/ml. Samples are sent to the Australian Synchrotron and data 
collected using the SAXS/WAXS beamline with the Pilatus 1M detector (170 mm x170 mm, 
effective pixel size, 172 x 172 m) as described (Keown, Griffin et al. 2013). The wavelength 
of the x-rays was 1.0332 Å. Each sample was flowed through 3 ml Superdex 200 5/150 gel 
filtration column (GE Healthcare), prior to passing through the beamline to ensure only 
protein will be present in the data and not any aggregate. As the samples are flowed through 
the beamline the different frames of the scatter are recorded.  
 
The scatter is analysed using Scatterbrain analysis (Australian Synchrotron) using images 
summed from the buffer and the most concentrated part of the protein sample. This data is 
then analysed using Primus (Konarev, Volkov et al. 2003, Petoukhov, Franke et al. 2012)  
.The theoretical scatter from the crystal structures are compared to the scatter produced from 
SAXS using Crysol (Svergun, Barberato et al. 1995) molecular weights were determined 
from SAXS using the SAXS MoW2 web tool(Fischer, Neto et al. 2010).  
 
 
5.10. Differential Scanning Fluorimetry 
 
Protein is concentrated to 0.5 mg/ml in 20 mM tris buffer10 mM pyruvate and 10 mM lysine 
are used as substrates to test for binding of substrates related to DHDPS. Protein samples are 
mixed with SYPRO® Orange (Sigma) at a 1000 fold dilution of the dye.  Four different 
conditions were employed per protein; one with only protein, two with either pyruvate or 
lysine present at 0.5 mg/ml concentrations and one condition with both pyruvate and lysine 
present. The thermal melt assay conducted by increasing the temperature to from 10⁰C in 
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increments of 0.5⁰C until a temperature of 100⁰C was reached. This was run with the Applied 
Biosystems™ QuantStudio™ 3 Real-Time PCR System.  
 
5.11. Assaying for DHDPS Activity 
 
DHDPS activity was assayed using a coupled DHDPS assay. This involves coupling the 
activity of DHDPS (or tHBPHA/HypD) with the activity of DHDPR (the next protein in the 
DAP pathway), with the change in NADPH measured through spectrophotometer as 
described in (Renwick C. J. DOBSON 2004). The assay was performed using 1 ml cuvettes 
which contained: 100 mM Hepes, ~0.162 mM NADPH, 20µg E. coli DHDPR and a set 
concentration of pyruvate and ASA at 50 mM. This is because the assay is to determine if 
activity is present. The protein concentrations are at 2 mg/ml within the cuvettes. The 
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